Jump to content
RemedySpot.com

Re: exercise harm in ME/enterovirus in muscle - a review;

Rate this topic


Guest guest

Recommended Posts

Hi All,

Thanks to everyone in this thread who answered my call for help on

this issue. I can't claim credit for the result, but I did pass on

the references people here supplied, and below is the result. The

principle author is interested in talking to Rich VK btw, if he's

watching!

It pretty much speaks for itself, but it is perhaps highlighting one

aspect from the get-go: competion for Glutatione between muscles and

the immune system. Over-exertion leads to muscles using up

glutathione (depleted in those with ME); the immune system becomes

less able to deal with infection as a result; any " dormant " viruses

then get let loose. So exercise can worsen symptoms and harm people.

I hope this is useful to people here.

Phil

------------------------------------------------------------

The physiology of exercise intolerance in patients with myalgic

encephalomyelitis (ME) and the utility of graded exercise therapy.

ABSTRACT:

This review discusses the suitability of graded exercise therapy for

the treatment of myalgic encephalomyelitis (ME), based on current

knowledge of the underlying physiology of the condition and the

physiological effects of exertion on ME patients. A large body of

peer-reviewed scientific literature supports the hypothesis that

with ME an initial over-exertion (a period of metabolic stress) in

conjunction with viral infection depletes concentrations of the

metabolic regulator glutathione, initiating a cascade of

physiological dysfunction. The immune system and muscle metabolism

(including the muscles of the cardiovascular system) continually

compete for glutathione, inducing a state of constant stress that

renders the condition chronic. The impairment of a range of

functions means that subtly different suites of symptoms are

apparent for different patients. Graded exercise therapy has proven

useful for a minority of these, and the exacerbation of symptoms for

the majority is not subjective but has a physiological basis.

Blanket recommendation of graded exercise therapy is not prudent for

such a heterogeneous group of patients, most of which are likely to

respond negatively to physical activity.

Following exercise, patients with myalgic encephalomyelitis (ME)

uniquely exhibit exacerbated symptoms and a suite of measurable

physiological changes indicative of stress (sub-optimal metabolic

performance; e.g. reduced respiration and heart rate, increased

glycolysis and lactic acid production, and concomitant limitation of

activity1-5). Although these symptoms may not be universal6, a

significant subgroup of ME patients are affected in this manner7.

The issue of exercise is critical for the treatment of the condition

as one school of thought recommends " graded exercise therapy " as a

general remedy for ME whilst another recognises that exercise

intolerance may have an underlying physiological cause that may

actually be aggravated by physical exertion. This difference of

opinion influences policy: graded exercise therapy is one of the

principal recommendations of the current NICE draft guidelines for

the treatment of patients " mildly to moderately affected " by ME (p.

21, lines 20 to 23) 8. Although recent general reviews of ME exist9-

11, our aim is to specifically review evidence for the mechanisms by

which physical activity affects ME patients, and to investigate how

graded exercise therapy may help or hinder recovery.

Although no single randomised controlled study has yet attempted to

investigate every aspect of ME, the combined weight of empirical

evidence to date indicates that the condition is characterised by a

complex series of events involving reserves of metabolic regulators

such as glutathione, muscle metabolism and the cardiovascular

system. A significant body of literature suggests that these

imbalances are associated with a dysfunctional immune system

impaired by viral infection. Indeed, a hallmark of ME is a range of

symptoms, varying in extent between patients, suggesting that a

range of functions are impaired to greater or lesser degrees.

ME typically follows a flu-like illness, with elevated

concentrations of viral particles subsequently detectable in blood

and muscle tissues12. Post-viral fatigue is a well established

possible consequence of infection by a range of different viruses13-

17, with enteroviruses specifically implicated in the case of ME –

elevated concentrations of viral RNA sequences resembling coxsackie

virus B are detectable in muscle tissue12. Furthermore, the majority

of the limited number of ME patients so far treated with antiviral

drugs (interferons) were able to return to work following

treatment18, also suggestive of a persistent `smoldering

infection'19.

Crucially, post-viral fatigue is not related to the muscle disuse

and deconditioning that can result from the initial period of

illness12. Indeed, the mechanism underpinning post-viral fatigue is

a multifaceted physiological imbalance. Nijs and co-workers20 found

that, for ME patients, graded exercise resulted in faulty regulation

of the immune system, specifically increased activity of the

enzymes " elastase " and " RNase L " . RNase L is a key component in the

cell's virus detection system and is up-regulated in response to

viral infection. However, elastase degrades RNase L and is normally

involved in removing it from the cell when concentrations are too

high. Why should both be highly expressed in ME patients? Elastase

is activated and degrades the RNase L in the absence of metabolic

regulators such as glutathione. (Glutathione is an amino acid

complex that modifies enzyme activity throughout the body, and ME

patients exhibit either lower concentrations or an imbalance between

its active and inactive forms21-23.) Thus the simultaneous over-

activation and mis-regulation of this part of the immune system can

be explained by glutathione depletion. A range of factors contribute

to glutathione depletion in the general population, including

infection, the oxidative stress induced by strenuous or sustained

exercise, and the long-

term elevation of the stress hormones cortisol and adrenalin24.

Furthermore, glutathione is also involved in sustaining respiration

(i.e. the production of chemical energy compounds such as ATP in the

mitochondria) thereby providing energy for active tissues such as

muscle. Thus muscle tissue effectively competes with the immune

system for glutathione25 – sustained physical activity reduces the

amount of glutathione available to the immune system, resulting in

immune dysfunction. Conversely, an overactive immune system reduces

the amount of energy available for muscle tissue, also exacerbating

oxidative stress, and can account for both the chronic fatigue and

pain (by inducing lactic acid production) that characterise ME.

Thus, following an initial period of stress, glutathione

concentrations may be too low for the optimal function of both the

immune system and muscle tissues, paving the way for both persistent

viral infection and fatigue, both of which feedback from each other

to render the condition chronic.

This situation is compounded by the fact that glutathione not only

has a supporting role in the immune response but also directly

inhibits the replication of enteroviruses by blocking the formation

of one particular protein (glycoprotein B) shared by all – including

coxsackie viruses. Indeed, glutathione concentration is a major

factor influencing the expression of other persistent viral

infections such as HIV26-29. Thus glutathione depletion not only

suppresses the immune system, it leaves the body particularly

defenceless against enteroviruses. Sustained exercise or stress can

deplete glutathione concentrations to the point where viral RNA is

no longer prevented from replicating, aiding either an initial

infection or the renewed replication of previously blocked viral RNA

present in muscle tissue and blood27,29. Thus glutathione depletion

is a strong candidate for `the trigger for reactivation of

endogenous latent viruses' in ME30. A small number of studies

demonstrate that foods rich in glutathione or direct glutathione

injection help to relieve fatigue in ME patients, and may clear

active viral infections31,32.

Although the above studies have concentrated on skeletal muscle, the

heart (and the postural leg muscle involved in pumping blood back to

the heart) is not exempt from glutathione depletion. Thus the above

mechanism can also account for the range of cardiovascular problems

associated with ME, including orthostatic (standing) intolerance

(reviewed by Spence and 33). Patients with orthostatic

intolerance `have continuous disability and commonly have exercise

intolerance'33.

Together, this evidence suggests that chronic fatigue in ME is

symptomatic of the following sequence of events: a period of

infection or strenuous physical or mental activity results in

glutathione depletion; this renders the immune system relatively

ineffective, particularly against enterovirus infection; the immune

system becomes constantly activated (and inefficiently governed)

because it has insufficient resources (glutathione) to completely

rid the body of viral particles; the constantly elevated energy

demand of the immune system detracts from other metabolic functions

(particularly energy-demanding systems such as skeletal muscles and

the cardiovascular system); limitation of respiratory and

cardiovascular systems further locks the patient into a vicious

cycle of inefficient energy production and use; increased reliance

on anaerobic metabolism leads to lactic acid production and

associated muscle pain.

Clearly, the performance of energy-demanding activities such as

exercise can only aggravate this situation. Indeed, 82 % of ME

patients in a recent study stated that graded exercise therapy

worsened their condition, and only 5 % found it useful (compared to

70 – 75 % of patients who found either pain management or `pacing'

of daily activities useful)34. Furthermore, the Canadian Clinical

Treatment Protocol warns that " externally paced `Graded Exercise

Programs' or programs based on the premise that patients are

misperceiving their activity limits or illness must be avoided " 35.

If exercise is so detrimental, why is graded exercise therapy often

recommended as a treatment for ME? Firstly, many of the studies

cited here are recent, and the information and implications have

perhaps not yet filtered up to policy makers. Secondly, the

reclassification of ME as an ambiguous `chronic fatigue syndrome'

(CFS) by members of the psychiatric profession assumes that the

symptoms have no physiological basis and are best treated with the

traditional psychiatric method of facing and overcoming a problem,

rather than direct removal of the problem at source. However, this

approach jumps from hypothesis to treatment without investigating

the mechanisms involved, perhaps explaining why " no psychiatrist has

ever cured an M.E. patient using psychiatric treatments " 19.

Psychiatry, by definition, should not have authority over the

treatment of physiological disorders, particularly those that occur

chiefly in muscle tissues. Graded exercise therapy is founded on,

and perpetuates, the myth that ME patients are simply malingering,

while most are frustrated by their incapacity to satisfactorily

conduct critical aspects of daily life34.

ME is a heterogeneous disorder that affects different patients to

varying degrees and with subtly different suites of symptoms. At

best, graded exercise therapy has relieved symptoms for (but not

cured) a tiny minority of patients, whilst the weight of empirical

evidence indicates that exercise has direct and persistently

negative impacts on the physiology and quality of life of a

significant subgroup of ME patients. Any universally applied therapy

is unlikely to address the heterogeneity of ME, and graded exercise

is particularly unsuitable as it may worsen the condition, and

should not be generally recommended without a high degree of

confidence that it will not be applied to susceptible patients: it

is difficult to conceive of a more inappropriate therapy for ME. By

increasing the risk of relapse and overall health risks, rather than

reducing them, graded exercise therapy also risks increasing the

burden of illness on society at large. The present review suggests

that an approach based on treatment of the underlying physiological

dysfunction will be more fruitful.

Abbreviations

ATP = Adenosine triphosphate, RNase L = 2',5'-oligoadenylate (2-5A)

synthetase/Ribonuclease L

Literature cited

1 De Becker PJ, Roeykens J, Reynders N, McGregor N & De Meirleir K.

2000. Exercise capacity in chronic fatigue syndrome. Archives of

International Medicine 160: 3270-3277.

2 Fulcher KY & White PD. 2000. Strength and physiological response

to exercise in patients with chronic fatigue syndrome. Journal of

Neurology, Neurosurgery, and Psychiatry 69: 302-307.

3 Wong R, Lopaschuk G, Zhu G, et al. 1992. Skeletal muscle

metabolism in the chronic fatigue syndrome: in vivo assessment by

31P nuclear magnetic resonance spectroscopy. Chest 102: 1716-1722.

4 Nus J, De Meirleir K, Wolfs S & Duquet W. 2004. Disability

evaluation in chronic fatigue syndrome: associations between

exercise capacity and activity limitations/participation

restrictions. Clinical Rehabilitation 18: 139-148.

5 Sorensen B. Streib JE, Strand M, et al. 2003. Complement

activation in a model of chronic fatique syndrome. Journal of

Allergy and Clinical Immunology 112: 397-403.

6 Sargent C, Scroop GC, Nemeth PM, Burnet RB & Buckley JD. 2002.

Maximal oxygen uptake and lactate metabolism are normal in chronic

fatigue syndrome. Medicine & Science in Sports and Exercise 34: 51-

56.

7 Chia JKS. 2005. The role of enterovirus in chronic fatigue

syndrome. Journal of Clinical Pathology 58: 1126-1132.

8 National Institute for Health and Clinical Excellence (NICE).

CFS/ME: full guideline DRAFT (September 2006).

9 Afari N & Buchwald D. 2003. Chronic fatigue syndrome: a review.

American Journal of Psychiatry 160: 221-236.

10 Patarca-Montero R, Antoni M, Fletcher MA & Klimas NG. 2001.

Cytokine and other immunologic markers in Chronic Fatigue Syndrome

and their relation to neuropsychological factors. Applied

Neuropsychology 8: 51-64.

11 Hooper M. 2006. Myalgic Encephalomyelitis (ME): a review with

emphasis on key findings in biomedical research. Journal of Clinical

Pathology (in press) published online 25 Aug. 2006 doi:

10.1136/jcp.2006.042408.

12 Lane RJM, Soteriou BA, Zhang H, & Archard LC. 2003. Enterovirus

related metabolic myopathy: a postviral fatigue syndrome. Journal of

Neurology, Neurosurgery, and Psychiatry 74: 1382-1386.

13 Ayres JG, Flint N, EG, et al. 1998. Post-infection fatigue

syndrome following Q-fever. Q. J. Med. 91: 105-123.

14 Berelowitz JG, Burgess AP, Thanabalasingham T, et al. 1995. Post-

hepatitis syndrome revisited. Journal of Viral Hepatitis 2: 133-138.

15 Kerr JR, Barah F, Matley DL. et al. 2001. Circulating tumour

necrosis factor-alpha and interferon-gamma are detectable during

acute and convalescent paravirus B19 infection and are associated

with prolonged and chronic fatigue. Journal of General Virology. 82:

3011-3019.

16 Hotopf M, Noah N, Wesseley S. 1996. Chronic fatigue and

psychiatric morbidity following viral meningitis: a controlled

study. Journal of Neurology, Neurosurgery, and Psychiatry 60: 495-

503.

17 White PD, JM, Amess J, et al. 1995. The existence of a

fatigue syndrome after glandular fever. Psychological Medicine 25:

907-916.

18 Chia JK, Jou NS, Majera L et al. 2001. The presence of

enteroviral RNA (EV RNA) in peripheral blood mononuclear cells

(PBMC) of patients with the chronic fatigue syndrome (CFS)

associated with high levels of neutralizing antibodies to

enteroviruses. Clinical Infectious Diseases 33: 1157.

19 Hyde B. 2006. A new and simple definition of myalgic

encephalomyelitis and a new simple definition of chronic fatigue

syndrome & a brief history of myalgic encephalomyelitis and an

irreverent history of chronic fatigue syndrome. Invest in ME, UK.

20 Nijs J, Meeus M, McGregor NR, Meeusen R, De Schutter G, Van Hoof

E & De Meirleir K. 2005. Chronic fatigue syndrome: exercise

performance related to immune dysfunction. Medicine & Science in

Sports and Exercise 37(10): 1647-1654.

21 s RS, TK, RH, McGregor NR & Butt HL. 2000.

Free radicals in chronic fatigue syndrome: cause or effect? Redox

Report 5(2-3): 146-147.

22 y Keenoy B, Moorkens G, Vertommen J, Noe M & De Leeuw I.

2000. Magnesium status and parameters of the oxidant-antioxidant

balance in patients with chronic fatigue: effects of supplementation

with magnesium. Journal of the American College of Nutrition 19(3):

374-382.

23 Kurup RK & Kurup PA. 2003. Hypothalamic digoxin, cerebral

chemical dominance and myalgic encephalomyelitis. International

Journal of Neuroscience 113: 683-701.

24 Ji LL. 1995. Oxidative stress during exercise: implication of

antioxidant nutrients. Free Radical Biology & Medicine 18(6): 1079-

1086.

25 Bounous G & Molson J. 1999. Competition for glutathione

precursors between the immune system and the skeletal muscle:

pathogenesis of chronic fatigue syndrome. Medical Hypotheses 53(4):

347-349.

26 Roederer M, Raju PA, Staal FJT, Herzenberg LA & Herzenberg LA.

1991. N-acetycysteine inhibits latent HIV expression in chronically

infected cells. AIDS Research and Human Retroviruses 7: 563-567.

27 Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D,

Deresinski SC, Ross W, Sussman H, Raju PA, MT, W, Ela

SW, Herzenberg LA & Herzenberg LA. 1992. Intracellular glutathione

levels in T cell subsets decrease in HIV-infected individuals. AIDS

Research and Human Retroviruses 8: 305-311.

28 Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bue MC, De Vito P,

Garaci E & Rotilio G. 1997. Loss of GSH, oxidative stress, and

decrease of intracellular pH as sequential steps in viral infection.

Journal of Biological Chemistry 272(5): 2700-2708.

29 Cai J, Chen Y, Seth S, Furukawa S, Compans RW & DP. 2003.

Inhibition of influenza infection by glutathione. Free Radical

Biology & Medicine 34(7): 928-936.

30 Van Konynenburg RA. 2004. Is glutathione depletion an important

part of the pathogenesis of chronic fatigue syndrome? Presented at

the AACFS Seventh International Conference, Oct. 8-10/2004, Madison,

Wisconsin.

31 Salvato P. 1998. CFIDS patients improve with glutathione

injections. CFIDS Chronicle January/February 1998.

32 Cheney PR. 1999. Evidence of glutathione deficiency in chronic

fatigue syndrome. American Biologics 11th International Symposium,

Vienna, Austria. Tape No. 07-199: available from Professional Audio

Recording, P.O. Box 7455, LaVerne, CA 91750.

33 Spence V & J. 2004. Standing up for ME. Biologist 51(2):

65-70.

34 25% ME Group. 2004. Severely affected ME (myalgic

encephalomyelitis) analysis report on a questionnaire issued January

2004. 25% ME Group, Troon, Ayrshire, UK. pp. 8.

35 Jain AK, Carruthers BM & Van de Sande MI. 2004. Fibromyalgia

Syndrome: Canadian Clinical Working Case Definition, Diagnostic and

Treatment Protocols-A Consensus Document. Journal of Musculoskeletal

Pain 11(4): 3-107.

Link to comment
Share on other sites

Thanks for this; is this published (or going to be), and where? And who are the

authors?

>

> Hi All,

>

> Thanks to everyone in this thread who answered my call for help on

> this issue. I can't claim credit for the result, but I did pass on

> the references people here supplied, and below is the result. The

> principle author is interested in talking to Rich VK btw, if he's

> watching!

>

> It pretty much speaks for itself, but it is perhaps highlighting one

> aspect from the get-go: competion for Glutatione between muscles and

> the immune system. Over-exertion leads to muscles using up

> glutathione (depleted in those with ME); the immune system becomes

> less able to deal with infection as a result; any " dormant " viruses

> then get let loose. So exercise can worsen symptoms and harm people.

>

> I hope this is useful to people here.

>

> Phil

>

> ------------------------------------------------------------

>

> The physiology of exercise intolerance in patients with myalgic

> encephalomyelitis (ME) and the utility of graded exercise therapy.

>

> ABSTRACT...

Link to comment
Share on other sites

Hi, Phil.

It is very gratifying to see that somebody is taking seriously some of

the things I've been writing. I would be very pleased to talk to the

principal author of this piece. My email address is richvank at aol

dot com.

Rich

>

> Hi All,

The

> principle author is interested in talking to Rich VK btw, if he's

> watching!

Link to comment
Share on other sites

Quote from article:

" Many CFS patients relate the onset of their symptoms to a preceding

viral infection from which they believe they failed to recover

fully. Evidence supporting such attribution had been largely

anecdotal until recent prospective studies found evidence of

protracted fatigue states following certain laboratory confirmed

infections, supporting the concept of a postviral or postinfectious

fatigue syndrome.4–7,11

We reported previously that a subset of CFS patients had abnormal

lactate responses to exercise at work rates below the predicted

anaerobic threshold.19 Such cases proved less likely to have

evidence of psychiatric disorder than cases with normal lactate

responses, and the finding could not be explained satisfactorily by

the effects of deconditioning or muscle disuse, either on the basis

of heart rate responses to exercise19 or from a subsequent analysis

of muscle fibre sizes and fibre type proportions.20 Further studies

using phosphorus magnetic resonance spectroscopy have shown that

some CFS patients have defective muscle energy metabolism,21–23

notably reduced ATP resynthesis rates following exercise, suggestive

of mitochondrial dysfunction.21 "

Wow. No " stress or stressors " " personality types " " diet " " exercise "

or " lack of exercise " involved.

A virus! Doesn't much care about your individual quirks.

What a concept!

-

Link to comment
Share on other sites

That fits me to a tee...but then, I can't believe that stress is

still an issue and we still have to hear people psychologize this

illness.

Would you please, let me know, whether Mold Warriors contains the

info that Desperation Medicine has, or does one have to buy both?

Also, is mold avoidance the main way you deal with mycotoxins? I

think that Cholestyramine would not be good for me...am thinking

Chronic Bowel Obstruction.

TIA,

Amelia

>

> Quote from article:

> " Many CFS patients relate the onset of their symptoms to a

preceding

> viral infection from which they believe they failed to recover

> fully. Evidence supporting such attribution had been largely

> anecdotal until recent prospective studies found evidence of

> protracted fatigue states following certain laboratory confirmed

> infections, supporting the concept of a postviral or postinfectious

> fatigue syndrome.4–7,11

>

> We reported previously that a subset of CFS patients had abnormal

> lactate responses to exercise at work rates below the predicted

> anaerobic threshold.19 Such cases proved less likely to have

> evidence of psychiatric disorder than cases with normal lactate

> responses, and the finding could not be explained satisfactorily by

> the effects of deconditioning or muscle disuse, either on the basis

> of heart rate responses to exercise19 or from a subsequent analysis

> of muscle fibre sizes and fibre type proportions.20 Further studies

> using phosphorus magnetic resonance spectroscopy have shown that

> some CFS patients have defective muscle energy metabolism,21–23

> notably reduced ATP resynthesis rates following exercise,

suggestive

> of mitochondrial dysfunction.21 "

>

> Wow. No " stress or stressors " " personality

types " " diet " " exercise "

> or " lack of exercise " involved.

> A virus! Doesn't much care about your individual quirks.

> What a concept!

> -

>

Link to comment
Share on other sites

" lifelonglearner79 " wrote:

> That fits me to a tee...but then, I can't believe that stress is

> still an issue and we still have to hear people psychologize this

> illness.

>

> Would you please, let me know, whether Mold Warriors contains the

> info that Desperation Medicine has, or does one have to buy both?

> Also, is mold avoidance the main way you deal with mycotoxins? I

> think that Cholestyramine would not be good for me...am thinking

> Chronic Bowel Obstruction.

> Amelia

I hear ya' on that!

In 2001 I moved into a place that put me " below the power curve " of

long term exposure - more than I could endure.

Wasn't all that ferocious, not like walking into a sick building,

but this adds up over time, and I could tell that I was

gradually " slipping " and heading in a very bad direction.

CSM only scrubs toxins after they've passed through and done their

damage. It's like cleaning up after the Hurricane, doesn't really

protect you in the midst of the storm.

For people " on the edge " , it helps a lot by keeping the mess a bit

better under control, but as long as the mess keeps piling up,

eventually you're gonna get buried.

I did try the CSM at that time, and it did seem to help, just a

bit, but my digestive tract came to a screaming halt.

I finally decided that I had " had enough of this s--t " and just

concentrated on total avoidance - and that's all I do.

And when I look back at all the things that people are trying, and

get a sense of what their results are, it makes me feel fortunate

that I chose to follow this path. Very difficult, complex, life

turned totally upside down - but beats the crap out of the

alternative.

-

Link to comment
Share on other sites

One of the most useful papers I have read. Where was it published?

Thanks Phil

Phil <fi11ip@...> wrote:

Hi All,

Thanks to everyone in this thread who answered my call for help on

this issue. I can't claim credit for the result, but I did pass on

the references people here supplied, and below is the result. The

principle author is interested in talking to Rich VK btw, if he's

watching!

It pretty much speaks for itself, but it is perhaps highlighting one

aspect from the get-go: competion for Glutatione between muscles and

the immune system. Over-exertion leads to muscles using up

glutathione (depleted in those with ME); the immune system becomes

less able to deal with infection as a result; any " dormant " viruses

then get let loose. So exercise can worsen symptoms and harm people.

I hope this is useful to people here.

Phil

----------------------------------------------------------

The physiology of exercise intolerance in patients with myalgic

encephalomyelitis (ME) and the utility of graded exercise therapy.

ABSTRACT:

This review discusses the suitability of graded exercise therapy for

the treatment of myalgic encephalomyelitis (ME), based on current

knowledge of the underlying physiology of the condition and the

physiological effects of exertion on ME patients. A large body of

peer-reviewed scientific literature supports the hypothesis that

with ME an initial over-exertion (a period of metabolic stress) in

conjunction with viral infection depletes concentrations of the

metabolic regulator glutathione, initiating a cascade of

physiological dysfunction. The immune system and muscle metabolism

(including the muscles of the cardiovascular system) continually

compete for glutathione, inducing a state of constant stress that

renders the condition chronic. The impairment of a range of

functions means that subtly different suites of symptoms are

apparent for different patients. Graded exercise therapy has proven

useful for a minority of these, and the exacerbation of symptoms for

the majority is not subjective but has a physiological basis.

Blanket recommendation of graded exercise therapy is not prudent for

such a heterogeneous group of patients, most of which are likely to

respond negatively to physical activity.

Following exercise, patients with myalgic encephalomyelitis (ME)

uniquely exhibit exacerbated symptoms and a suite of measurable

physiological changes indicative of stress (sub-optimal metabolic

performance; e.g. reduced respiration and heart rate, increased

glycolysis and lactic acid production, and concomitant limitation of

activity1-5). Although these symptoms may not be universal6, a

significant subgroup of ME patients are affected in this manner7.

The issue of exercise is critical for the treatment of the condition

as one school of thought recommends " graded exercise therapy " as a

general remedy for ME whilst another recognises that exercise

intolerance may have an underlying physiological cause that may

actually be aggravated by physical exertion. This difference of

opinion influences policy: graded exercise therapy is one of the

principal recommendations of the current NICE draft guidelines for

the treatment of patients " mildly to moderately affected " by ME (p.

21, lines 20 to 23) 8. Although recent general reviews of ME exist9-

11, our aim is to specifically review evidence for the mechanisms by

which physical activity affects ME patients, and to investigate how

graded exercise therapy may help or hinder recovery.

Although no single randomised controlled study has yet attempted to

investigate every aspect of ME, the combined weight of empirical

evidence to date indicates that the condition is characterised by a

complex series of events involving reserves of metabolic regulators

such as glutathione, muscle metabolism and the cardiovascular

system. A significant body of literature suggests that these

imbalances are associated with a dysfunctional immune system

impaired by viral infection. Indeed, a hallmark of ME is a range of

symptoms, varying in extent between patients, suggesting that a

range of functions are impaired to greater or lesser degrees.

ME typically follows a flu-like illness, with elevated

concentrations of viral particles subsequently detectable in blood

and muscle tissues12. Post-viral fatigue is a well established

possible consequence of infection by a range of different viruses13-

17, with enteroviruses specifically implicated in the case of ME –

elevated concentrations of viral RNA sequences resembling coxsackie

virus B are detectable in muscle tissue12. Furthermore, the majority

of the limited number of ME patients so far treated with antiviral

drugs (interferons) were able to return to work following

treatment18, also suggestive of a persistent `smoldering

infection'19.

Crucially, post-viral fatigue is not related to the muscle disuse

and deconditioning that can result from the initial period of

illness12. Indeed, the mechanism underpinning post-viral fatigue is

a multifaceted physiological imbalance. Nijs and co-workers20 found

that, for ME patients, graded exercise resulted in faulty regulation

of the immune system, specifically increased activity of the

enzymes " elastase " and " RNase L " . RNase L is a key component in the

cell's virus detection system and is up-regulated in response to

viral infection. However, elastase degrades RNase L and is normally

involved in removing it from the cell when concentrations are too

high. Why should both be highly expressed in ME patients? Elastase

is activated and degrades the RNase L in the absence of metabolic

regulators such as glutathione. (Glutathione is an amino acid

complex that modifies enzyme activity throughout the body, and ME

patients exhibit either lower concentrations or an imbalance between

its active and inactive forms21-23.) Thus the simultaneous over-

activation and mis-regulation of this part of the immune system can

be explained by glutathione depletion. A range of factors contribute

to glutathione depletion in the general population, including

infection, the oxidative stress induced by strenuous or sustained

exercise, and the long-

term elevation of the stress hormones cortisol and adrenalin24.

Furthermore, glutathione is also involved in sustaining respiration

(i.e. the production of chemical energy compounds such as ATP in the

mitochondria) thereby providing energy for active tissues such as

muscle. Thus muscle tissue effectively competes with the immune

system for glutathione25 – sustained physical activity reduces the

amount of glutathione available to the immune system, resulting in

immune dysfunction. Conversely, an overactive immune system reduces

the amount of energy available for muscle tissue, also exacerbating

oxidative stress, and can account for both the chronic fatigue and

pain (by inducing lactic acid production) that characterise ME.

Thus, following an initial period of stress, glutathione

concentrations may be too low for the optimal function of both the

immune system and muscle tissues, paving the way for both persistent

viral infection and fatigue, both of which feedback from each other

to render the condition chronic.

This situation is compounded by the fact that glutathione not only

has a supporting role in the immune response but also directly

inhibits the replication of enteroviruses by blocking the formation

of one particular protein (glycoprotein B) shared by all – including

coxsackie viruses. Indeed, glutathione concentration is a major

factor influencing the expression of other persistent viral

infections such as HIV26-29. Thus glutathione depletion not only

suppresses the immune system, it leaves the body particularly

defenceless against enteroviruses. Sustained exercise or stress can

deplete glutathione concentrations to the point where viral RNA is

no longer prevented from replicating, aiding either an initial

infection or the renewed replication of previously blocked viral RNA

present in muscle tissue and blood27,29. Thus glutathione depletion

is a strong candidate for `the trigger for reactivation of

endogenous latent viruses' in ME30. A small number of studies

demonstrate that foods rich in glutathione or direct glutathione

injection help to relieve fatigue in ME patients, and may clear

active viral infections31,32.

Although the above studies have concentrated on skeletal muscle, the

heart (and the postural leg muscle involved in pumping blood back to

the heart) is not exempt from glutathione depletion. Thus the above

mechanism can also account for the range of cardiovascular problems

associated with ME, including orthostatic (standing) intolerance

(reviewed by Spence and 33). Patients with orthostatic

intolerance `have continuous disability and commonly have exercise

intolerance'33.

Together, this evidence suggests that chronic fatigue in ME is

symptomatic of the following sequence of events: a period of

infection or strenuous physical or mental activity results in

glutathione depletion; this renders the immune system relatively

ineffective, particularly against enterovirus infection; the immune

system becomes constantly activated (and inefficiently governed)

because it has insufficient resources (glutathione) to completely

rid the body of viral particles; the constantly elevated energy

demand of the immune system detracts from other metabolic functions

(particularly energy-demanding systems such as skeletal muscles and

the cardiovascular system); limitation of respiratory and

cardiovascular systems further locks the patient into a vicious

cycle of inefficient energy production and use; increased reliance

on anaerobic metabolism leads to lactic acid production and

associated muscle pain.

Clearly, the performance of energy-demanding activities such as

exercise can only aggravate this situation. Indeed, 82 % of ME

patients in a recent study stated that graded exercise therapy

worsened their condition, and only 5 % found it useful (compared to

70 – 75 % of patients who found either pain management or `pacing'

of daily activities useful)34. Furthermore, the Canadian Clinical

Treatment Protocol warns that " externally paced `Graded Exercise

Programs' or programs based on the premise that patients are

misperceiving their activity limits or illness must be avoided " 35.

If exercise is so detrimental, why is graded exercise therapy often

recommended as a treatment for ME? Firstly, many of the studies

cited here are recent, and the information and implications have

perhaps not yet filtered up to policy makers. Secondly, the

reclassification of ME as an ambiguous `chronic fatigue syndrome'

(CFS) by members of the psychiatric profession assumes that the

symptoms have no physiological basis and are best treated with the

traditional psychiatric method of facing and overcoming a problem,

rather than direct removal of the problem at source. However, this

approach jumps from hypothesis to treatment without investigating

the mechanisms involved, perhaps explaining why " no psychiatrist has

ever cured an M.E. patient using psychiatric treatments " 19.

Psychiatry, by definition, should not have authority over the

treatment of physiological disorders, particularly those that occur

chiefly in muscle tissues. Graded exercise therapy is founded on,

and perpetuates, the myth that ME patients are simply malingering,

while most are frustrated by their incapacity to satisfactorily

conduct critical aspects of daily life34.

ME is a heterogeneous disorder that affects different patients to

varying degrees and with subtly different suites of symptoms. At

best, graded exercise therapy has relieved symptoms for (but not

cured) a tiny minority of patients, whilst the weight of empirical

evidence indicates that exercise has direct and persistently

negative impacts on the physiology and quality of life of a

significant subgroup of ME patients. Any universally applied therapy

is unlikely to address the heterogeneity of ME, and graded exercise

is particularly unsuitable as it may worsen the condition, and

should not be generally recommended without a high degree of

confidence that it will not be applied to susceptible patients: it

is difficult to conceive of a more inappropriate therapy for ME. By

increasing the risk of relapse and overall health risks, rather than

reducing them, graded exercise therapy also risks increasing the

burden of illness on society at large. The present review suggests

that an approach based on treatment of the underlying physiological

dysfunction will be more fruitful.

Abbreviations

ATP = Adenosine triphosphate, RNase L = 2',5'-oligoadenylate (2-5A)

synthetase/Ribonuclease L

Literature cited

1 De Becker PJ, Roeykens J, Reynders N, McGregor N & De Meirleir K.

2000. Exercise capacity in chronic fatigue syndrome. Archives of

International Medicine 160: 3270-3277.

2 Fulcher KY & White PD. 2000. Strength and physiological response

to exercise in patients with chronic fatigue syndrome. Journal of

Neurology, Neurosurgery, and Psychiatry 69: 302-307.

3 Wong R, Lopaschuk G, Zhu G, et al. 1992. Skeletal muscle

metabolism in the chronic fatigue syndrome: in vivo assessment by

31P nuclear magnetic resonance spectroscopy. Chest 102: 1716-1722.

4 Nus J, De Meirleir K, Wolfs S & Duquet W. 2004. Disability

evaluation in chronic fatigue syndrome: associations between

exercise capacity and activity limitations/participation

restrictions. Clinical Rehabilitation 18: 139-148.

5 Sorensen B. Streib JE, Strand M, et al. 2003. Complement

activation in a model of chronic fatique syndrome. Journal of

Allergy and Clinical Immunology 112: 397-403.

6 Sargent C, Scroop GC, Nemeth PM, Burnet RB & Buckley JD. 2002.

Maximal oxygen uptake and lactate metabolism are normal in chronic

fatigue syndrome. Medicine & Science in Sports and Exercise 34: 51-

56.

7 Chia JKS. 2005. The role of enterovirus in chronic fatigue

syndrome. Journal of Clinical Pathology 58: 1126-1132.

8 National Institute for Health and Clinical Excellence (NICE).

CFS/ME: full guideline DRAFT (September 2006).

9 Afari N & Buchwald D. 2003. Chronic fatigue syndrome: a review.

American Journal of Psychiatry 160: 221-236.

10 Patarca-Montero R, Antoni M, Fletcher MA & Klimas NG. 2001.

Cytokine and other immunologic markers in Chronic Fatigue Syndrome

and their relation to neuropsychological factors. Applied

Neuropsychology 8: 51-64.

11 Hooper M. 2006. Myalgic Encephalomyelitis (ME): a review with

emphasis on key findings in biomedical research. Journal of Clinical

Pathology (in press) published online 25 Aug. 2006 doi:

10.1136/jcp.2006.042408.

12 Lane RJM, Soteriou BA, Zhang H, & Archard LC. 2003. Enterovirus

related metabolic myopathy: a postviral fatigue syndrome. Journal of

Neurology, Neurosurgery, and Psychiatry 74: 1382-1386.

13 Ayres JG, Flint N, EG, et al. 1998. Post-infection fatigue

syndrome following Q-fever. Q. J. Med. 91: 105-123.

14 Berelowitz JG, Burgess AP, Thanabalasingham T, et al. 1995. Post-

hepatitis syndrome revisited. Journal of Viral Hepatitis 2: 133-138.

15 Kerr JR, Barah F, Matley DL. et al. 2001. Circulating tumour

necrosis factor-alpha and interferon-gamma are detectable during

acute and convalescent paravirus B19 infection and are associated

with prolonged and chronic fatigue. Journal of General Virology. 82:

3011-3019.

16 Hotopf M, Noah N, Wesseley S. 1996. Chronic fatigue and

psychiatric morbidity following viral meningitis: a controlled

study. Journal of Neurology, Neurosurgery, and Psychiatry 60: 495-

503.

17 White PD, JM, Amess J, et al. 1995. The existence of a

fatigue syndrome after glandular fever. Psychological Medicine 25:

907-916.

18 Chia JK, Jou NS, Majera L et al. 2001. The presence of

enteroviral RNA (EV RNA) in peripheral blood mononuclear cells

(PBMC) of patients with the chronic fatigue syndrome (CFS)

associated with high levels of neutralizing antibodies to

enteroviruses. Clinical Infectious Diseases 33: 1157.

19 Hyde B. 2006. A new and simple definition of myalgic

encephalomyelitis and a new simple definition of chronic fatigue

syndrome & a brief history of myalgic encephalomyelitis and an

irreverent history of chronic fatigue syndrome. Invest in ME, UK.

20 Nijs J, Meeus M, McGregor NR, Meeusen R, De Schutter G, Van Hoof

E & De Meirleir K. 2005. Chronic fatigue syndrome: exercise

performance related to immune dysfunction. Medicine & Science in

Sports and Exercise 37(10): 1647-1654.

21 s RS, TK, RH, McGregor NR & Butt HL. 2000.

Free radicals in chronic fatigue syndrome: cause or effect? Redox

Report 5(2-3): 146-147.

22 y Keenoy B, Moorkens G, Vertommen J, Noe M & De Leeuw I.

2000. Magnesium status and parameters of the oxidant-antioxidant

balance in patients with chronic fatigue: effects of supplementation

with magnesium. Journal of the American College of Nutrition 19(3):

374-382.

23 Kurup RK & Kurup PA. 2003. Hypothalamic digoxin, cerebral

chemical dominance and myalgic encephalomyelitis. International

Journal of Neuroscience 113: 683-701.

24 Ji LL. 1995. Oxidative stress during exercise: implication of

antioxidant nutrients. Free Radical Biology & Medicine 18(6): 1079-

1086.

25 Bounous G & Molson J. 1999. Competition for glutathione

precursors between the immune system and the skeletal muscle:

pathogenesis of chronic fatigue syndrome. Medical Hypotheses 53(4):

347-349.

26 Roederer M, Raju PA, Staal FJT, Herzenberg LA & Herzenberg LA.

1991. N-acetycysteine inhibits latent HIV expression in chronically

infected cells. AIDS Research and Human Retroviruses 7: 563-567.

27 Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane D,

Deresinski SC, Ross W, Sussman H, Raju PA, MT, W, Ela

SW, Herzenberg LA & Herzenberg LA. 1992. Intracellular glutathione

levels in T cell subsets decrease in HIV-infected individuals. AIDS

Research and Human Retroviruses 8: 305-311.

28 Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bue MC, De Vito P,

Garaci E & Rotilio G. 1997. Loss of GSH, oxidative stress, and

decrease of intracellular pH as sequential steps in viral infection.

Journal of Biological Chemistry 272(5): 2700-2708.

29 Cai J, Chen Y, Seth S, Furukawa S, Compans RW & DP. 2003.

Inhibition of influenza infection by glutathione. Free Radical

Biology & Medicine 34(7): 928-936.

30 Van Konynenburg RA. 2004. Is glutathione depletion an important

part of the pathogenesis of chronic fatigue syndrome? Presented at

the AACFS Seventh International Conference, Oct. 8-10/2004, Madison,

Wisconsin.

31 Salvato P. 1998. CFIDS patients improve with glutathione

injections. CFIDS Chronicle January/February 1998.

32 Cheney PR. 1999. Evidence of glutathione deficiency in chronic

fatigue syndrome. American Biologics 11th International Symposium,

Vienna, Austria. Tape No. 07-199: available from Professional Audio

Recording, P.O. Box 7455, LaVerne, CA 91750.

33 Spence V & J. 2004. Standing up for ME. Biologist 51(2):

65-70.

34 25% ME Group. 2004. Severely affected ME (myalgic

encephalomyelitis) analysis report on a questionnaire issued January

2004. 25% ME Group, Troon, Ayrshire, UK. pp. 8.

35 Jain AK, Carruthers BM & Van de Sande MI. 2004. Fibromyalgia

Syndrome: Canadian Clinical Working Case Definition, Diagnostic and

Treatment Protocols-A Consensus Document. Journal of Musculoskeletal

Pain 11(4): 3-107.

---------------------------------

Any questions? Get answers on any topic at Answers. Try it now.

Link to comment
Share on other sites

Hi,

It's " in press " as they say, but we are hoping to publish it. In the

meantime anyone is free to use the ideas, but until it is published,

quoting it may not carry so much weight. The important thing is to

get across the point that in ME/CFS, exercise = bad.

Phil

PS Louella, are you italian?

> Hi All,

>

> Thanks to everyone in this thread who answered my call for help on

> this issue. I can't claim credit for the result, but I did pass on

> the references people here supplied, and below is the result. The

> principle author is interested in talking to Rich VK btw, if he's

> watching!

>

> It pretty much speaks for itself, but it is perhaps highlighting

one

> aspect from the get-go: competion for Glutatione between muscles

and

> the immune system. Over-exertion leads to muscles using up

> glutathione (depleted in those with ME); the immune system becomes

> less able to deal with infection as a result; any " dormant "

viruses

> then get let loose. So exercise can worsen symptoms and harm

people.

>

> I hope this is useful to people here.

>

> Phil

>

> ----------------------------------------------------------

>

> The physiology of exercise intolerance in patients with myalgic

> encephalomyelitis (ME) and the utility of graded exercise therapy.

>

> ABSTRACT:

> This review discusses the suitability of graded exercise therapy

for

> the treatment of myalgic encephalomyelitis (ME), based on current

> knowledge of the underlying physiology of the condition and the

> physiological effects of exertion on ME patients. A large body of

> peer-reviewed scientific literature supports the hypothesis that

> with ME an initial over-exertion (a period of metabolic stress) in

> conjunction with viral infection depletes concentrations of the

> metabolic regulator glutathione, initiating a cascade of

> physiological dysfunction. The immune system and muscle metabolism

> (including the muscles of the cardiovascular system) continually

> compete for glutathione, inducing a state of constant stress that

> renders the condition chronic. The impairment of a range of

> functions means that subtly different suites of symptoms are

> apparent for different patients. Graded exercise therapy has

proven

> useful for a minority of these, and the exacerbation of symptoms

for

> the majority is not subjective but has a physiological basis.

> Blanket recommendation of graded exercise therapy is not prudent

for

> such a heterogeneous group of patients, most of which are likely

to

> respond negatively to physical activity.

>

> Following exercise, patients with myalgic encephalomyelitis (ME)

> uniquely exhibit exacerbated symptoms and a suite of measurable

> physiological changes indicative of stress (sub-optimal metabolic

> performance; e.g. reduced respiration and heart rate, increased

> glycolysis and lactic acid production, and concomitant limitation

of

> activity1-5). Although these symptoms may not be universal6, a

> significant subgroup of ME patients are affected in this manner7.

> The issue of exercise is critical for the treatment of the

condition

> as one school of thought recommends " graded exercise therapy " as a

> general remedy for ME whilst another recognises that exercise

> intolerance may have an underlying physiological cause that may

> actually be aggravated by physical exertion. This difference of

> opinion influences policy: graded exercise therapy is one of the

> principal recommendations of the current NICE draft guidelines for

> the treatment of patients " mildly to moderately affected " by ME

(p.

> 21, lines 20 to 23) 8. Although recent general reviews of ME

exist9-

> 11, our aim is to specifically review evidence for the mechanisms

by

> which physical activity affects ME patients, and to investigate

how

> graded exercise therapy may help or hinder recovery.

> Although no single randomised controlled study has yet attempted

to

> investigate every aspect of ME, the combined weight of empirical

> evidence to date indicates that the condition is characterised by

a

> complex series of events involving reserves of metabolic

regulators

> such as glutathione, muscle metabolism and the cardiovascular

> system. A significant body of literature suggests that these

> imbalances are associated with a dysfunctional immune system

> impaired by viral infection. Indeed, a hallmark of ME is a range

of

> symptoms, varying in extent between patients, suggesting that a

> range of functions are impaired to greater or lesser degrees.

> ME typically follows a flu-like illness, with elevated

> concentrations of viral particles subsequently detectable in blood

> and muscle tissues12. Post-viral fatigue is a well established

> possible consequence of infection by a range of different

viruses13-

> 17, with enteroviruses specifically implicated in the case of ME –

> elevated concentrations of viral RNA sequences resembling

coxsackie

> virus B are detectable in muscle tissue12. Furthermore, the

majority

> of the limited number of ME patients so far treated with antiviral

> drugs (interferons) were able to return to work following

> treatment18, also suggestive of a persistent `smoldering

> infection'19.

> Crucially, post-viral fatigue is not related to the muscle disuse

> and deconditioning that can result from the initial period of

> illness12. Indeed, the mechanism underpinning post-viral fatigue

is

> a multifaceted physiological imbalance. Nijs and co-workers20

found

> that, for ME patients, graded exercise resulted in faulty

regulation

> of the immune system, specifically increased activity of the

> enzymes " elastase " and " RNase L " . RNase L is a key component in

the

> cell's virus detection system and is up-regulated in response to

> viral infection. However, elastase degrades RNase L and is

normally

> involved in removing it from the cell when concentrations are too

> high. Why should both be highly expressed in ME patients? Elastase

> is activated and degrades the RNase L in the absence of metabolic

> regulators such as glutathione. (Glutathione is an amino acid

> complex that modifies enzyme activity throughout the body, and ME

> patients exhibit either lower concentrations or an imbalance

between

> its active and inactive forms21-23.) Thus the simultaneous over-

> activation and mis-regulation of this part of the immune system

can

> be explained by glutathione depletion. A range of factors

contribute

> to glutathione depletion in the general population, including

> infection, the oxidative stress induced by strenuous or sustained

> exercise, and the long-

> term elevation of the stress hormones cortisol and adrenalin24.

> Furthermore, glutathione is also involved in sustaining

respiration

> (i.e. the production of chemical energy compounds such as ATP in

the

> mitochondria) thereby providing energy for active tissues such as

> muscle. Thus muscle tissue effectively competes with the immune

> system for glutathione25 – sustained physical activity reduces the

> amount of glutathione available to the immune system, resulting in

> immune dysfunction. Conversely, an overactive immune system

reduces

> the amount of energy available for muscle tissue, also

exacerbating

> oxidative stress, and can account for both the chronic fatigue and

> pain (by inducing lactic acid production) that characterise ME.

> Thus, following an initial period of stress, glutathione

> concentrations may be too low for the optimal function of both the

> immune system and muscle tissues, paving the way for both

persistent

> viral infection and fatigue, both of which feedback from each

other

> to render the condition chronic.

> This situation is compounded by the fact that glutathione not only

> has a supporting role in the immune response but also directly

> inhibits the replication of enteroviruses by blocking the

formation

> of one particular protein (glycoprotein B) shared by all –

including

> coxsackie viruses. Indeed, glutathione concentration is a major

> factor influencing the expression of other persistent viral

> infections such as HIV26-29. Thus glutathione depletion not only

> suppresses the immune system, it leaves the body particularly

> defenceless against enteroviruses. Sustained exercise or stress

can

> deplete glutathione concentrations to the point where viral RNA is

> no longer prevented from replicating, aiding either an initial

> infection or the renewed replication of previously blocked viral

RNA

> present in muscle tissue and blood27,29. Thus glutathione

depletion

> is a strong candidate for `the trigger for reactivation of

> endogenous latent viruses' in ME30. A small number of studies

> demonstrate that foods rich in glutathione or direct glutathione

> injection help to relieve fatigue in ME patients, and may clear

> active viral infections31,32.

> Although the above studies have concentrated on skeletal muscle,

the

> heart (and the postural leg muscle involved in pumping blood back

to

> the heart) is not exempt from glutathione depletion. Thus the

above

> mechanism can also account for the range of cardiovascular

problems

> associated with ME, including orthostatic (standing) intolerance

> (reviewed by Spence and 33). Patients with orthostatic

> intolerance `have continuous disability and commonly have exercise

> intolerance'33.

> Together, this evidence suggests that chronic fatigue in ME is

> symptomatic of the following sequence of events: a period of

> infection or strenuous physical or mental activity results in

> glutathione depletion; this renders the immune system relatively

> ineffective, particularly against enterovirus infection; the

immune

> system becomes constantly activated (and inefficiently governed)

> because it has insufficient resources (glutathione) to completely

> rid the body of viral particles; the constantly elevated energy

> demand of the immune system detracts from other metabolic

functions

> (particularly energy-demanding systems such as skeletal muscles

and

> the cardiovascular system); limitation of respiratory and

> cardiovascular systems further locks the patient into a vicious

> cycle of inefficient energy production and use; increased reliance

> on anaerobic metabolism leads to lactic acid production and

> associated muscle pain.

> Clearly, the performance of energy-demanding activities such as

> exercise can only aggravate this situation. Indeed, 82 % of ME

> patients in a recent study stated that graded exercise therapy

> worsened their condition, and only 5 % found it useful (compared

to

> 70 – 75 % of patients who found either pain management or `pacing'

> of daily activities useful)34. Furthermore, the Canadian Clinical

> Treatment Protocol warns that " externally paced `Graded Exercise

> Programs' or programs based on the premise that patients are

> misperceiving their activity limits or illness must be avoided " 35.

> If exercise is so detrimental, why is graded exercise therapy

often

> recommended as a treatment for ME? Firstly, many of the studies

> cited here are recent, and the information and implications have

> perhaps not yet filtered up to policy makers. Secondly, the

> reclassification of ME as an ambiguous `chronic fatigue syndrome'

> (CFS) by members of the psychiatric profession assumes that the

> symptoms have no physiological basis and are best treated with the

> traditional psychiatric method of facing and overcoming a problem,

> rather than direct removal of the problem at source. However, this

> approach jumps from hypothesis to treatment without investigating

> the mechanisms involved, perhaps explaining why " no psychiatrist

has

> ever cured an M.E. patient using psychiatric treatments " 19.

> Psychiatry, by definition, should not have authority over the

> treatment of physiological disorders, particularly those that

occur

> chiefly in muscle tissues. Graded exercise therapy is founded on,

> and perpetuates, the myth that ME patients are simply malingering,

> while most are frustrated by their incapacity to satisfactorily

> conduct critical aspects of daily life34.

> ME is a heterogeneous disorder that affects different patients to

> varying degrees and with subtly different suites of symptoms. At

> best, graded exercise therapy has relieved symptoms for (but not

> cured) a tiny minority of patients, whilst the weight of empirical

> evidence indicates that exercise has direct and persistently

> negative impacts on the physiology and quality of life of a

> significant subgroup of ME patients. Any universally applied

therapy

> is unlikely to address the heterogeneity of ME, and graded

exercise

> is particularly unsuitable as it may worsen the condition, and

> should not be generally recommended without a high degree of

> confidence that it will not be applied to susceptible patients: it

> is difficult to conceive of a more inappropriate therapy for ME.

By

> increasing the risk of relapse and overall health risks, rather

than

> reducing them, graded exercise therapy also risks increasing the

> burden of illness on society at large. The present review suggests

> that an approach based on treatment of the underlying

physiological

> dysfunction will be more fruitful.

>

> Abbreviations

> ATP = Adenosine triphosphate, RNase L = 2',5'-oligoadenylate (2-

5A)

> synthetase/Ribonuclease L

> Literature cited

> 1 De Becker PJ, Roeykens J, Reynders N, McGregor N & De Meirleir

K.

> 2000. Exercise capacity in chronic fatigue syndrome. Archives of

> International Medicine 160: 3270-3277.

> 2 Fulcher KY & White PD. 2000. Strength and physiological response

> to exercise in patients with chronic fatigue syndrome. Journal of

> Neurology, Neurosurgery, and Psychiatry 69: 302-307.

> 3 Wong R, Lopaschuk G, Zhu G, et al. 1992. Skeletal muscle

> metabolism in the chronic fatigue syndrome: in vivo assessment by

> 31P nuclear magnetic resonance spectroscopy. Chest 102: 1716-1722.

> 4 Nus J, De Meirleir K, Wolfs S & Duquet W. 2004. Disability

> evaluation in chronic fatigue syndrome: associations between

> exercise capacity and activity limitations/participation

> restrictions. Clinical Rehabilitation 18: 139-148.

> 5 Sorensen B. Streib JE, Strand M, et al. 2003. Complement

> activation in a model of chronic fatique syndrome. Journal of

> Allergy and Clinical Immunology 112: 397-403.

> 6 Sargent C, Scroop GC, Nemeth PM, Burnet RB & Buckley JD. 2002.

> Maximal oxygen uptake and lactate metabolism are normal in chronic

> fatigue syndrome. Medicine & Science in Sports and Exercise 34: 51-

> 56.

> 7 Chia JKS. 2005. The role of enterovirus in chronic fatigue

> syndrome. Journal of Clinical Pathology 58: 1126-1132.

> 8 National Institute for Health and Clinical Excellence (NICE).

> CFS/ME: full guideline DRAFT (September 2006).

> 9 Afari N & Buchwald D. 2003. Chronic fatigue syndrome: a review.

> American Journal of Psychiatry 160: 221-236.

> 10 Patarca-Montero R, Antoni M, Fletcher MA & Klimas NG. 2001.

> Cytokine and other immunologic markers in Chronic Fatigue Syndrome

> and their relation to neuropsychological factors. Applied

> Neuropsychology 8: 51-64.

> 11 Hooper M. 2006. Myalgic Encephalomyelitis (ME): a review with

> emphasis on key findings in biomedical research. Journal of

Clinical

> Pathology (in press) published online 25 Aug. 2006 doi:

> 10.1136/jcp.2006.042408.

> 12 Lane RJM, Soteriou BA, Zhang H, & Archard LC. 2003. Enterovirus

> related metabolic myopathy: a postviral fatigue syndrome. Journal

of

> Neurology, Neurosurgery, and Psychiatry 74: 1382-1386.

> 13 Ayres JG, Flint N, EG, et al. 1998. Post-infection

fatigue

> syndrome following Q-fever. Q. J. Med. 91: 105-123.

> 14 Berelowitz JG, Burgess AP, Thanabalasingham T, et al. 1995.

Post-

> hepatitis syndrome revisited. Journal of Viral Hepatitis 2: 133-

138.

> 15 Kerr JR, Barah F, Matley DL. et al. 2001. Circulating tumour

> necrosis factor-alpha and interferon-gamma are detectable during

> acute and convalescent paravirus B19 infection and are associated

> with prolonged and chronic fatigue. Journal of General Virology.

82:

> 3011-3019.

> 16 Hotopf M, Noah N, Wesseley S. 1996. Chronic fatigue and

> psychiatric morbidity following viral meningitis: a controlled

> study. Journal of Neurology, Neurosurgery, and Psychiatry 60: 495-

> 503.

> 17 White PD, JM, Amess J, et al. 1995. The existence of a

> fatigue syndrome after glandular fever. Psychological Medicine 25:

> 907-916.

> 18 Chia JK, Jou NS, Majera L et al. 2001. The presence of

> enteroviral RNA (EV RNA) in peripheral blood mononuclear cells

> (PBMC) of patients with the chronic fatigue syndrome (CFS)

> associated with high levels of neutralizing antibodies to

> enteroviruses. Clinical Infectious Diseases 33: 1157.

> 19 Hyde B. 2006. A new and simple definition of myalgic

> encephalomyelitis and a new simple definition of chronic fatigue

> syndrome & a brief history of myalgic encephalomyelitis and an

> irreverent history of chronic fatigue syndrome. Invest in ME, UK.

> 20 Nijs J, Meeus M, McGregor NR, Meeusen R, De Schutter G, Van

Hoof

> E & De Meirleir K. 2005. Chronic fatigue syndrome: exercise

> performance related to immune dysfunction. Medicine & Science in

> Sports and Exercise 37(10): 1647-1654.

> 21 s RS, TK, RH, McGregor NR & Butt HL.

2000.

> Free radicals in chronic fatigue syndrome: cause or effect? Redox

> Report 5(2-3): 146-147.

> 22 y Keenoy B, Moorkens G, Vertommen J, Noe M & De Leeuw I.

> 2000. Magnesium status and parameters of the oxidant-antioxidant

> balance in patients with chronic fatigue: effects of

supplementation

> with magnesium. Journal of the American College of Nutrition 19

(3):

> 374-382.

> 23 Kurup RK & Kurup PA. 2003. Hypothalamic digoxin, cerebral

> chemical dominance and myalgic encephalomyelitis. International

> Journal of Neuroscience 113: 683-701.

> 24 Ji LL. 1995. Oxidative stress during exercise: implication of

> antioxidant nutrients. Free Radical Biology & Medicine 18(6): 1079-

> 1086.

> 25 Bounous G & Molson J. 1999. Competition for glutathione

> precursors between the immune system and the skeletal muscle:

> pathogenesis of chronic fatigue syndrome. Medical Hypotheses 53

(4):

> 347-349.

> 26 Roederer M, Raju PA, Staal FJT, Herzenberg LA & Herzenberg LA.

> 1991. N-acetycysteine inhibits latent HIV expression in

chronically

> infected cells. AIDS Research and Human Retroviruses 7: 563-567.

> 27 Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane

D,

> Deresinski SC, Ross W, Sussman H, Raju PA, MT, W,

Ela

> SW, Herzenberg LA & Herzenberg LA. 1992. Intracellular glutathione

> levels in T cell subsets decrease in HIV-infected individuals.

AIDS

> Research and Human Retroviruses 8: 305-311.

> 28 Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bue MC, De Vito

P,

> Garaci E & Rotilio G. 1997. Loss of GSH, oxidative stress, and

> decrease of intracellular pH as sequential steps in viral

infection.

> Journal of Biological Chemistry 272(5): 2700-2708.

> 29 Cai J, Chen Y, Seth S, Furukawa S, Compans RW & DP. 2003.

> Inhibition of influenza infection by glutathione. Free Radical

> Biology & Medicine 34(7): 928-936.

> 30 Van Konynenburg RA. 2004. Is glutathione depletion an important

> part of the pathogenesis of chronic fatigue syndrome? Presented at

> the AACFS Seventh International Conference, Oct. 8-10/2004,

Madison,

> Wisconsin.

> 31 Salvato P. 1998. CFIDS patients improve with glutathione

> injections. CFIDS Chronicle January/February 1998.

> 32 Cheney PR. 1999. Evidence of glutathione deficiency in chronic

> fatigue syndrome. American Biologics 11th International Symposium,

> Vienna, Austria. Tape No. 07-199: available from Professional

Audio

> Recording, P.O. Box 7455, LaVerne, CA 91750.

> 33 Spence V & J. 2004. Standing up for ME. Biologist 51

(2):

> 65-70.

> 34 25% ME Group. 2004. Severely affected ME (myalgic

> encephalomyelitis) analysis report on a questionnaire issued

January

> 2004. 25% ME Group, Troon, Ayrshire, UK. pp. 8.

> 35 Jain AK, Carruthers BM & Van de Sande MI. 2004. Fibromyalgia

> Syndrome: Canadian Clinical Working Case Definition, Diagnostic

and

> Treatment Protocols-A Consensus Document. Journal of

Musculoskeletal

> Pain 11(4): 3-107.

>

>

>

>

>

>

> ---------------------------------

> Any questions? Get answers on any topic at Answers. Try it

now.

>

>

Link to comment
Share on other sites

hi phil

ok. can u say where the researchers are from? which academic institution or

whatever?

and nope not Italian. Irish origin actually.

Louella

Phil <fi11ip@...> wrote:

Hi,

It's " in press " as they say, but we are hoping to publish it. In the

meantime anyone is free to use the ideas, but until it is published,

quoting it may not carry so much weight. The important thing is to

get across the point that in ME/CFS, exercise = bad.

Phil

PS Louella, are you italian?

> Hi All,

>

> Thanks to everyone in this thread who answered my call for help on

> this issue. I can't claim credit for the result, but I did pass on

> the references people here supplied, and below is the result. The

> principle author is interested in talking to Rich VK btw, if he's

> watching!

>

> It pretty much speaks for itself, but it is perhaps highlighting

one

> aspect from the get-go: competion for Glutatione between muscles

and

> the immune system. Over-exertion leads to muscles using up

> glutathione (depleted in those with ME); the immune system becomes

> less able to deal with infection as a result; any " dormant "

viruses

> then get let loose. So exercise can worsen symptoms and harm

people.

>

> I hope this is useful to people here.

>

> Phil

>

> ----------------------------------------------------------

>

> The physiology of exercise intolerance in patients with myalgic

> encephalomyelitis (ME) and the utility of graded exercise therapy.

>

> ABSTRACT:

> This review discusses the suitability of graded exercise therapy

for

> the treatment of myalgic encephalomyelitis (ME), based on current

> knowledge of the underlying physiology of the condition and the

> physiological effects of exertion on ME patients. A large body of

> peer-reviewed scientific literature supports the hypothesis that

> with ME an initial over-exertion (a period of metabolic stress) in

> conjunction with viral infection depletes concentrations of the

> metabolic regulator glutathione, initiating a cascade of

> physiological dysfunction. The immune system and muscle metabolism

> (including the muscles of the cardiovascular system) continually

> compete for glutathione, inducing a state of constant stress that

> renders the condition chronic. The impairment of a range of

> functions means that subtly different suites of symptoms are

> apparent for different patients. Graded exercise therapy has

proven

> useful for a minority of these, and the exacerbation of symptoms

for

> the majority is not subjective but has a physiological basis.

> Blanket recommendation of graded exercise therapy is not prudent

for

> such a heterogeneous group of patients, most of which are likely

to

> respond negatively to physical activity.

>

> Following exercise, patients with myalgic encephalomyelitis (ME)

> uniquely exhibit exacerbated symptoms and a suite of measurable

> physiological changes indicative of stress (sub-optimal metabolic

> performance; e.g. reduced respiration and heart rate, increased

> glycolysis and lactic acid production, and concomitant limitation

of

> activity1-5). Although these symptoms may not be universal6, a

> significant subgroup of ME patients are affected in this manner7.

> The issue of exercise is critical for the treatment of the

condition

> as one school of thought recommends " graded exercise therapy " as a

> general remedy for ME whilst another recognises that exercise

> intolerance may have an underlying physiological cause that may

> actually be aggravated by physical exertion. This difference of

> opinion influences policy: graded exercise therapy is one of the

> principal recommendations of the current NICE draft guidelines for

> the treatment of patients " mildly to moderately affected " by ME

(p.

> 21, lines 20 to 23) 8. Although recent general reviews of ME

exist9-

> 11, our aim is to specifically review evidence for the mechanisms

by

> which physical activity affects ME patients, and to investigate

how

> graded exercise therapy may help or hinder recovery.

> Although no single randomised controlled study has yet attempted

to

> investigate every aspect of ME, the combined weight of empirical

> evidence to date indicates that the condition is characterised by

a

> complex series of events involving reserves of metabolic

regulators

> such as glutathione, muscle metabolism and the cardiovascular

> system. A significant body of literature suggests that these

> imbalances are associated with a dysfunctional immune system

> impaired by viral infection. Indeed, a hallmark of ME is a range

of

> symptoms, varying in extent between patients, suggesting that a

> range of functions are impaired to greater or lesser degrees.

> ME typically follows a flu-like illness, with elevated

> concentrations of viral particles subsequently detectable in blood

> and muscle tissues12. Post-viral fatigue is a well established

> possible consequence of infection by a range of different

viruses13-

> 17, with enteroviruses specifically implicated in the case of ME –

> elevated concentrations of viral RNA sequences resembling

coxsackie

> virus B are detectable in muscle tissue12. Furthermore, the

majority

> of the limited number of ME patients so far treated with antiviral

> drugs (interferons) were able to return to work following

> treatment18, also suggestive of a persistent `smoldering

> infection'19.

> Crucially, post-viral fatigue is not related to the muscle disuse

> and deconditioning that can result from the initial period of

> illness12. Indeed, the mechanism underpinning post-viral fatigue

is

> a multifaceted physiological imbalance. Nijs and co-workers20

found

> that, for ME patients, graded exercise resulted in faulty

regulation

> of the immune system, specifically increased activity of the

> enzymes " elastase " and " RNase L " . RNase L is a key component in

the

> cell's virus detection system and is up-regulated in response to

> viral infection. However, elastase degrades RNase L and is

normally

> involved in removing it from the cell when concentrations are too

> high. Why should both be highly expressed in ME patients? Elastase

> is activated and degrades the RNase L in the absence of metabolic

> regulators such as glutathione. (Glutathione is an amino acid

> complex that modifies enzyme activity throughout the body, and ME

> patients exhibit either lower concentrations or an imbalance

between

> its active and inactive forms21-23.) Thus the simultaneous over-

> activation and mis-regulation of this part of the immune system

can

> be explained by glutathione depletion. A range of factors

contribute

> to glutathione depletion in the general population, including

> infection, the oxidative stress induced by strenuous or sustained

> exercise, and the long-

> term elevation of the stress hormones cortisol and adrenalin24.

> Furthermore, glutathione is also involved in sustaining

respiration

> (i.e. the production of chemical energy compounds such as ATP in

the

> mitochondria) thereby providing energy for active tissues such as

> muscle. Thus muscle tissue effectively competes with the immune

> system for glutathione25 – sustained physical activity reduces the

> amount of glutathione available to the immune system, resulting in

> immune dysfunction. Conversely, an overactive immune system

reduces

> the amount of energy available for muscle tissue, also

exacerbating

> oxidative stress, and can account for both the chronic fatigue and

> pain (by inducing lactic acid production) that characterise ME.

> Thus, following an initial period of stress, glutathione

> concentrations may be too low for the optimal function of both the

> immune system and muscle tissues, paving the way for both

persistent

> viral infection and fatigue, both of which feedback from each

other

> to render the condition chronic.

> This situation is compounded by the fact that glutathione not only

> has a supporting role in the immune response but also directly

> inhibits the replication of enteroviruses by blocking the

formation

> of one particular protein (glycoprotein B) shared by all –

including

> coxsackie viruses. Indeed, glutathione concentration is a major

> factor influencing the expression of other persistent viral

> infections such as HIV26-29. Thus glutathione depletion not only

> suppresses the immune system, it leaves the body particularly

> defenceless against enteroviruses. Sustained exercise or stress

can

> deplete glutathione concentrations to the point where viral RNA is

> no longer prevented from replicating, aiding either an initial

> infection or the renewed replication of previously blocked viral

RNA

> present in muscle tissue and blood27,29. Thus glutathione

depletion

> is a strong candidate for `the trigger for reactivation of

> endogenous latent viruses' in ME30. A small number of studies

> demonstrate that foods rich in glutathione or direct glutathione

> injection help to relieve fatigue in ME patients, and may clear

> active viral infections31,32.

> Although the above studies have concentrated on skeletal muscle,

the

> heart (and the postural leg muscle involved in pumping blood back

to

> the heart) is not exempt from glutathione depletion. Thus the

above

> mechanism can also account for the range of cardiovascular

problems

> associated with ME, including orthostatic (standing) intolerance

> (reviewed by Spence and 33). Patients with orthostatic

> intolerance `have continuous disability and commonly have exercise

> intolerance'33.

> Together, this evidence suggests that chronic fatigue in ME is

> symptomatic of the following sequence of events: a period of

> infection or strenuous physical or mental activity results in

> glutathione depletion; this renders the immune system relatively

> ineffective, particularly against enterovirus infection; the

immune

> system becomes constantly activated (and inefficiently governed)

> because it has insufficient resources (glutathione) to completely

> rid the body of viral particles; the constantly elevated energy

> demand of the immune system detracts from other metabolic

functions

> (particularly energy-demanding systems such as skeletal muscles

and

> the cardiovascular system); limitation of respiratory and

> cardiovascular systems further locks the patient into a vicious

> cycle of inefficient energy production and use; increased reliance

> on anaerobic metabolism leads to lactic acid production and

> associated muscle pain.

> Clearly, the performance of energy-demanding activities such as

> exercise can only aggravate this situation. Indeed, 82 % of ME

> patients in a recent study stated that graded exercise therapy

> worsened their condition, and only 5 % found it useful (compared

to

> 70 – 75 % of patients who found either pain management or `pacing'

> of daily activities useful)34. Furthermore, the Canadian Clinical

> Treatment Protocol warns that " externally paced `Graded Exercise

> Programs' or programs based on the premise that patients are

> misperceiving their activity limits or illness must be avoided " 35.

> If exercise is so detrimental, why is graded exercise therapy

often

> recommended as a treatment for ME? Firstly, many of the studies

> cited here are recent, and the information and implications have

> perhaps not yet filtered up to policy makers. Secondly, the

> reclassification of ME as an ambiguous `chronic fatigue syndrome'

> (CFS) by members of the psychiatric profession assumes that the

> symptoms have no physiological basis and are best treated with the

> traditional psychiatric method of facing and overcoming a problem,

> rather than direct removal of the problem at source. However, this

> approach jumps from hypothesis to treatment without investigating

> the mechanisms involved, perhaps explaining why " no psychiatrist

has

> ever cured an M.E. patient using psychiatric treatments " 19.

> Psychiatry, by definition, should not have authority over the

> treatment of physiological disorders, particularly those that

occur

> chiefly in muscle tissues. Graded exercise therapy is founded on,

> and perpetuates, the myth that ME patients are simply malingering,

> while most are frustrated by their incapacity to satisfactorily

> conduct critical aspects of daily life34.

> ME is a heterogeneous disorder that affects different patients to

> varying degrees and with subtly different suites of symptoms. At

> best, graded exercise therapy has relieved symptoms for (but not

> cured) a tiny minority of patients, whilst the weight of empirical

> evidence indicates that exercise has direct and persistently

> negative impacts on the physiology and quality of life of a

> significant subgroup of ME patients. Any universally applied

therapy

> is unlikely to address the heterogeneity of ME, and graded

exercise

> is particularly unsuitable as it may worsen the condition, and

> should not be generally recommended without a high degree of

> confidence that it will not be applied to susceptible patients: it

> is difficult to conceive of a more inappropriate therapy for ME.

By

> increasing the risk of relapse and overall health risks, rather

than

> reducing them, graded exercise therapy also risks increasing the

> burden of illness on society at large. The present review suggests

> that an approach based on treatment of the underlying

physiological

> dysfunction will be more fruitful.

>

> Abbreviations

> ATP = Adenosine triphosphate, RNase L = 2',5'-oligoadenylate (2-

5A)

> synthetase/Ribonuclease L

> Literature cited

> 1 De Becker PJ, Roeykens J, Reynders N, McGregor N & De Meirleir

K.

> 2000. Exercise capacity in chronic fatigue syndrome. Archives of

> International Medicine 160: 3270-3277.

> 2 Fulcher KY & White PD. 2000. Strength and physiological response

> to exercise in patients with chronic fatigue syndrome. Journal of

> Neurology, Neurosurgery, and Psychiatry 69: 302-307.

> 3 Wong R, Lopaschuk G, Zhu G, et al. 1992. Skeletal muscle

> metabolism in the chronic fatigue syndrome: in vivo assessment by

> 31P nuclear magnetic resonance spectroscopy. Chest 102: 1716-1722.

> 4 Nus J, De Meirleir K, Wolfs S & Duquet W. 2004. Disability

> evaluation in chronic fatigue syndrome: associations between

> exercise capacity and activity limitations/participation

> restrictions. Clinical Rehabilitation 18: 139-148.

> 5 Sorensen B. Streib JE, Strand M, et al. 2003. Complement

> activation in a model of chronic fatique syndrome. Journal of

> Allergy and Clinical Immunology 112: 397-403.

> 6 Sargent C, Scroop GC, Nemeth PM, Burnet RB & Buckley JD. 2002.

> Maximal oxygen uptake and lactate metabolism are normal in chronic

> fatigue syndrome. Medicine & Science in Sports and Exercise 34: 51-

> 56.

> 7 Chia JKS. 2005. The role of enterovirus in chronic fatigue

> syndrome. Journal of Clinical Pathology 58: 1126-1132.

> 8 National Institute for Health and Clinical Excellence (NICE).

> CFS/ME: full guideline DRAFT (September 2006).

> 9 Afari N & Buchwald D. 2003. Chronic fatigue syndrome: a review.

> American Journal of Psychiatry 160: 221-236.

> 10 Patarca-Montero R, Antoni M, Fletcher MA & Klimas NG. 2001.

> Cytokine and other immunologic markers in Chronic Fatigue Syndrome

> and their relation to neuropsychological factors. Applied

> Neuropsychology 8: 51-64.

> 11 Hooper M. 2006. Myalgic Encephalomyelitis (ME): a review with

> emphasis on key findings in biomedical research. Journal of

Clinical

> Pathology (in press) published online 25 Aug. 2006 doi:

> 10.1136/jcp.2006.042408.

> 12 Lane RJM, Soteriou BA, Zhang H, & Archard LC. 2003. Enterovirus

> related metabolic myopathy: a postviral fatigue syndrome. Journal

of

> Neurology, Neurosurgery, and Psychiatry 74: 1382-1386.

> 13 Ayres JG, Flint N, EG, et al. 1998. Post-infection

fatigue

> syndrome following Q-fever. Q. J. Med. 91: 105-123.

> 14 Berelowitz JG, Burgess AP, Thanabalasingham T, et al. 1995.

Post-

> hepatitis syndrome revisited. Journal of Viral Hepatitis 2: 133-

138.

> 15 Kerr JR, Barah F, Matley DL. et al. 2001. Circulating tumour

> necrosis factor-alpha and interferon-gamma are detectable during

> acute and convalescent paravirus B19 infection and are associated

> with prolonged and chronic fatigue. Journal of General Virology.

82:

> 3011-3019.

> 16 Hotopf M, Noah N, Wesseley S. 1996. Chronic fatigue and

> psychiatric morbidity following viral meningitis: a controlled

> study. Journal of Neurology, Neurosurgery, and Psychiatry 60: 495-

> 503.

> 17 White PD, JM, Amess J, et al. 1995. The existence of a

> fatigue syndrome after glandular fever. Psychological Medicine 25:

> 907-916.

> 18 Chia JK, Jou NS, Majera L et al. 2001. The presence of

> enteroviral RNA (EV RNA) in peripheral blood mononuclear cells

> (PBMC) of patients with the chronic fatigue syndrome (CFS)

> associated with high levels of neutralizing antibodies to

> enteroviruses. Clinical Infectious Diseases 33: 1157.

> 19 Hyde B. 2006. A new and simple definition of myalgic

> encephalomyelitis and a new simple definition of chronic fatigue

> syndrome & a brief history of myalgic encephalomyelitis and an

> irreverent history of chronic fatigue syndrome. Invest in ME, UK.

> 20 Nijs J, Meeus M, McGregor NR, Meeusen R, De Schutter G, Van

Hoof

> E & De Meirleir K. 2005. Chronic fatigue syndrome: exercise

> performance related to immune dysfunction. Medicine & Science in

> Sports and Exercise 37(10): 1647-1654.

> 21 s RS, TK, RH, McGregor NR & Butt HL.

2000.

> Free radicals in chronic fatigue syndrome: cause or effect? Redox

> Report 5(2-3): 146-147.

> 22 y Keenoy B, Moorkens G, Vertommen J, Noe M & De Leeuw I.

> 2000. Magnesium status and parameters of the oxidant-antioxidant

> balance in patients with chronic fatigue: effects of

supplementation

> with magnesium. Journal of the American College of Nutrition 19

(3):

> 374-382.

> 23 Kurup RK & Kurup PA. 2003. Hypothalamic digoxin, cerebral

> chemical dominance and myalgic encephalomyelitis. International

> Journal of Neuroscience 113: 683-701.

> 24 Ji LL. 1995. Oxidative stress during exercise: implication of

> antioxidant nutrients. Free Radical Biology & Medicine 18(6): 1079-

> 1086.

> 25 Bounous G & Molson J. 1999. Competition for glutathione

> precursors between the immune system and the skeletal muscle:

> pathogenesis of chronic fatigue syndrome. Medical Hypotheses 53

(4):

> 347-349.

> 26 Roederer M, Raju PA, Staal FJT, Herzenberg LA & Herzenberg LA.

> 1991. N-acetycysteine inhibits latent HIV expression in

chronically

> infected cells. AIDS Research and Human Retroviruses 7: 563-567.

> 27 Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane

D,

> Deresinski SC, Ross W, Sussman H, Raju PA, MT, W,

Ela

> SW, Herzenberg LA & Herzenberg LA. 1992. Intracellular glutathione

> levels in T cell subsets decrease in HIV-infected individuals.

AIDS

> Research and Human Retroviruses 8: 305-311.

> 28 Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bue MC, De Vito

P,

> Garaci E & Rotilio G. 1997. Loss of GSH, oxidative stress, and

> decrease of intracellular pH as sequential steps in viral

infection.

> Journal of Biological Chemistry 272(5): 2700-2708.

> 29 Cai J, Chen Y, Seth S, Furukawa S, Compans RW & DP. 2003.

> Inhibition of influenza infection by glutathione. Free Radical

> Biology & Medicine 34(7): 928-936.

> 30 Van Konynenburg RA. 2004. Is glutathione depletion an important

> part of the pathogenesis of chronic fatigue syndrome? Presented at

> the AACFS Seventh International Conference, Oct. 8-10/2004,

Madison,

> Wisconsin.

> 31 Salvato P. 1998. CFIDS patients improve with glutathione

> injections. CFIDS Chronicle January/February 1998.

> 32 Cheney PR. 1999. Evidence of glutathione deficiency in chronic

> fatigue syndrome. American Biologics 11th International Symposium,

> Vienna, Austria. Tape No. 07-199: available from Professional

Audio

> Recording, P.O. Box 7455, LaVerne, CA 91750.

> 33 Spence V & J. 2004. Standing up for ME. Biologist 51

(2):

> 65-70.

> 34 25% ME Group. 2004. Severely affected ME (myalgic

> encephalomyelitis) analysis report on a questionnaire issued

January

> 2004. 25% ME Group, Troon, Ayrshire, UK. pp. 8.

> 35 Jain AK, Carruthers BM & Van de Sande MI. 2004. Fibromyalgia

> Syndrome: Canadian Clinical Working Case Definition, Diagnostic

and

> Treatment Protocols-A Consensus Document. Journal of

Musculoskeletal

> Pain 11(4): 3-107.

>

>

>

>

>

>

> ---------------------------------

> Any questions? Get answers on any topic at Answers. Try it

now.

>

>

Link to comment
Share on other sites

Very interesting article, Phil. In one part of the study, it said

that there were some foods that helped raise glutathione. Does

anyone know what those foods might be, or are they referring to whey?

Mike C

> > Hi All,

> >

> > Thanks to everyone in this thread who answered my call for help

on

> > this issue. I can't claim credit for the result, but I did pass

on

> > the references people here supplied, and below is the result. The

> > principle author is interested in talking to Rich VK btw, if he's

> > watching!

> >

> > It pretty much speaks for itself, but it is perhaps highlighting

> one

> > aspect from the get-go: competion for Glutatione between muscles

> and

> > the immune system. Over-exertion leads to muscles using up

> > glutathione (depleted in those with ME); the immune system

becomes

> > less able to deal with infection as a result; any " dormant "

> viruses

> > then get let loose. So exercise can worsen symptoms and harm

> people.

> >

> > I hope this is useful to people here.

> >

> > Phil

> >

> > ----------------------------------------------------------

> >

> > The physiology of exercise intolerance in patients with myalgic

> > encephalomyelitis (ME) and the utility of graded exercise therapy.

> >

> > ABSTRACT:

> > This review discusses the suitability of graded exercise therapy

> for

> > the treatment of myalgic encephalomyelitis (ME), based on current

> > knowledge of the underlying physiology of the condition and the

> > physiological effects of exertion on ME patients. A large body of

> > peer-reviewed scientific literature supports the hypothesis that

> > with ME an initial over-exertion (a period of metabolic stress)

in

> > conjunction with viral infection depletes concentrations of the

> > metabolic regulator glutathione, initiating a cascade of

> > physiological dysfunction. The immune system and muscle<<snip>>

Link to comment
Share on other sites

Mike,

I suspect that Rich and other regulars here may know more about this

than we do. The main thing was using peer-reviewed work (where

possible) to establish a bullet-proof scientific link between

exercise and the harm it can do to PWME, to try and influence health

policy here in the UK.

Phil

> > > Hi All,

> > >

> > > Thanks to everyone in this thread who answered my call for

help

> on

> > > this issue. I can't claim credit for the result, but I did

pass

> on

> > > the references people here supplied, and below is the result.

The

> > > principle author is interested in talking to Rich VK btw, if

he's

> > > watching!

> > >

> > > It pretty much speaks for itself, but it is perhaps

highlighting

> > one

> > > aspect from the get-go: competion for Glutatione between

muscles

> > and

> > > the immune system. Over-exertion leads to muscles using up

> > > glutathione (depleted in those with ME); the immune system

> becomes

> > > less able to deal with infection as a result; any " dormant "

> > viruses

> > > then get let loose. So exercise can worsen symptoms and harm

> > people.

> > >

> > > I hope this is useful to people here.

> > >

> > > Phil

> > >

> > > ----------------------------------------------------------

> > >

> > > The physiology of exercise intolerance in patients with

myalgic

> > > encephalomyelitis (ME) and the utility of graded exercise

therapy.

> > >

> > > ABSTRACT:

> > > This review discusses the suitability of graded exercise

therapy

> > for

> > > the treatment of myalgic encephalomyelitis (ME), based on

current

> > > knowledge of the underlying physiology of the condition and

the

> > > physiological effects of exertion on ME patients. A large body

of

> > > peer-reviewed scientific literature supports the hypothesis

that

> > > with ME an initial over-exertion (a period of metabolic

stress)

> in

> > > conjunction with viral infection depletes concentrations of

the

> > > metabolic regulator glutathione, initiating a cascade of

> > > physiological dysfunction. The immune system and muscle<<snip>>

>

Link to comment
Share on other sites

Lets just say they're new to the field! Please forgive the

evasiveness for now...

> > Hi All,

> >

> > Thanks to everyone in this thread who answered my call for help

on

> > this issue. I can't claim credit for the result, but I did pass

on

> > the references people here supplied, and below is the result.

The

> > principle author is interested in talking to Rich VK btw, if

he's

> > watching!

> >

> > It pretty much speaks for itself, but it is perhaps highlighting

> one

> > aspect from the get-go: competion for Glutatione between muscles

> and

> > the immune system. Over-exertion leads to muscles using up

> > glutathione (depleted in those with ME); the immune system

becomes

> > less able to deal with infection as a result; any " dormant "

> viruses

> > then get let loose. So exercise can worsen symptoms and harm

> people.

> >

> > I hope this is useful to people here.

> >

> > Phil

> >

> > ----------------------------------------------------------

> >

> > The physiology of exercise intolerance in patients with myalgic

> > encephalomyelitis (ME) and the utility of graded exercise

therapy.

> >

> > ABSTRACT:

> > This review discusses the suitability of graded exercise therapy

> for

> > the treatment of myalgic encephalomyelitis (ME), based on

current

> > knowledge of the underlying physiology of the condition and the

> > physiological effects of exertion on ME patients. A large body

of

> > peer-reviewed scientific literature supports the hypothesis that

> > with ME an initial over-exertion (a period of metabolic stress)

in

> > conjunction with viral infection depletes concentrations of the

> > metabolic regulator glutathione, initiating a cascade of

> > physiological dysfunction. The immune system and muscle

metabolism

> > (including the muscles of the cardiovascular system) continually

> > compete for glutathione, inducing a state of constant stress

that

> > renders the condition chronic. The impairment of a range of

> > functions means that subtly different suites of symptoms are

> > apparent for different patients. Graded exercise therapy has

> proven

> > useful for a minority of these, and the exacerbation of symptoms

> for

> > the majority is not subjective but has a physiological basis.

> > Blanket recommendation of graded exercise therapy is not prudent

> for

> > such a heterogeneous group of patients, most of which are likely

> to

> > respond negatively to physical activity.

> >

> > Following exercise, patients with myalgic encephalomyelitis (ME)

> > uniquely exhibit exacerbated symptoms and a suite of measurable

> > physiological changes indicative of stress (sub-optimal

metabolic

> > performance; e.g. reduced respiration and heart rate, increased

> > glycolysis and lactic acid production, and concomitant

limitation

> of

> > activity1-5). Although these symptoms may not be universal6, a

> > significant subgroup of ME patients are affected in this

manner7.

> > The issue of exercise is critical for the treatment of the

> condition

> > as one school of thought recommends " graded exercise therapy " as

a

> > general remedy for ME whilst another recognises that exercise

> > intolerance may have an underlying physiological cause that may

> > actually be aggravated by physical exertion. This difference of

> > opinion influences policy: graded exercise therapy is one of the

> > principal recommendations of the current NICE draft guidelines

for

> > the treatment of patients " mildly to moderately affected " by ME

> (p.

> > 21, lines 20 to 23) 8. Although recent general reviews of ME

> exist9-

> > 11, our aim is to specifically review evidence for the

mechanisms

> by

> > which physical activity affects ME patients, and to investigate

> how

> > graded exercise therapy may help or hinder recovery.

> > Although no single randomised controlled study has yet attempted

> to

> > investigate every aspect of ME, the combined weight of empirical

> > evidence to date indicates that the condition is characterised

by

> a

> > complex series of events involving reserves of metabolic

> regulators

> > such as glutathione, muscle metabolism and the cardiovascular

> > system. A significant body of literature suggests that these

> > imbalances are associated with a dysfunctional immune system

> > impaired by viral infection. Indeed, a hallmark of ME is a range

> of

> > symptoms, varying in extent between patients, suggesting that a

> > range of functions are impaired to greater or lesser degrees.

> > ME typically follows a flu-like illness, with elevated

> > concentrations of viral particles subsequently detectable in

blood

> > and muscle tissues12. Post-viral fatigue is a well established

> > possible consequence of infection by a range of different

> viruses13-

> > 17, with enteroviruses specifically implicated in the case of

ME –

> > elevated concentrations of viral RNA sequences resembling

> coxsackie

> > virus B are detectable in muscle tissue12. Furthermore, the

> majority

> > of the limited number of ME patients so far treated with

antiviral

> > drugs (interferons) were able to return to work following

> > treatment18, also suggestive of a persistent `smoldering

> > infection'19.

> > Crucially, post-viral fatigue is not related to the muscle

disuse

> > and deconditioning that can result from the initial period of

> > illness12. Indeed, the mechanism underpinning post-viral fatigue

> is

> > a multifaceted physiological imbalance. Nijs and co-workers20

> found

> > that, for ME patients, graded exercise resulted in faulty

> regulation

> > of the immune system, specifically increased activity of the

> > enzymes " elastase " and " RNase L " . RNase L is a key component in

> the

> > cell's virus detection system and is up-regulated in response to

> > viral infection. However, elastase degrades RNase L and is

> normally

> > involved in removing it from the cell when concentrations are

too

> > high. Why should both be highly expressed in ME patients?

Elastase

> > is activated and degrades the RNase L in the absence of

metabolic

> > regulators such as glutathione. (Glutathione is an amino acid

> > complex that modifies enzyme activity throughout the body, and

ME

> > patients exhibit either lower concentrations or an imbalance

> between

> > its active and inactive forms21-23.) Thus the simultaneous over-

> > activation and mis-regulation of this part of the immune system

> can

> > be explained by glutathione depletion. A range of factors

> contribute

> > to glutathione depletion in the general population, including

> > infection, the oxidative stress induced by strenuous or

sustained

> > exercise, and the long-

> > term elevation of the stress hormones cortisol and adrenalin24.

> > Furthermore, glutathione is also involved in sustaining

> respiration

> > (i.e. the production of chemical energy compounds such as ATP in

> the

> > mitochondria) thereby providing energy for active tissues such

as

> > muscle. Thus muscle tissue effectively competes with the immune

> > system for glutathione25 – sustained physical activity reduces

the

> > amount of glutathione available to the immune system, resulting

in

> > immune dysfunction. Conversely, an overactive immune system

> reduces

> > the amount of energy available for muscle tissue, also

> exacerbating

> > oxidative stress, and can account for both the chronic fatigue

and

> > pain (by inducing lactic acid production) that characterise ME.

> > Thus, following an initial period of stress, glutathione

> > concentrations may be too low for the optimal function of both

the

> > immune system and muscle tissues, paving the way for both

> persistent

> > viral infection and fatigue, both of which feedback from each

> other

> > to render the condition chronic.

> > This situation is compounded by the fact that glutathione not

only

> > has a supporting role in the immune response but also directly

> > inhibits the replication of enteroviruses by blocking the

> formation

> > of one particular protein (glycoprotein B) shared by all –

> including

> > coxsackie viruses. Indeed, glutathione concentration is a major

> > factor influencing the expression of other persistent viral

> > infections such as HIV26-29. Thus glutathione depletion not only

> > suppresses the immune system, it leaves the body particularly

> > defenceless against enteroviruses. Sustained exercise or stress

> can

> > deplete glutathione concentrations to the point where viral RNA

is

> > no longer prevented from replicating, aiding either an initial

> > infection or the renewed replication of previously blocked viral

> RNA

> > present in muscle tissue and blood27,29. Thus glutathione

> depletion

> > is a strong candidate for `the trigger for reactivation of

> > endogenous latent viruses' in ME30. A small number of studies

> > demonstrate that foods rich in glutathione or direct glutathione

> > injection help to relieve fatigue in ME patients, and may clear

> > active viral infections31,32.

> > Although the above studies have concentrated on skeletal muscle,

> the

> > heart (and the postural leg muscle involved in pumping blood

back

> to

> > the heart) is not exempt from glutathione depletion. Thus the

> above

> > mechanism can also account for the range of cardiovascular

> problems

> > associated with ME, including orthostatic (standing) intolerance

> > (reviewed by Spence and 33). Patients with orthostatic

> > intolerance `have continuous disability and commonly have

exercise

> > intolerance'33.

> > Together, this evidence suggests that chronic fatigue in ME is

> > symptomatic of the following sequence of events: a period of

> > infection or strenuous physical or mental activity results in

> > glutathione depletion; this renders the immune system relatively

> > ineffective, particularly against enterovirus infection; the

> immune

> > system becomes constantly activated (and inefficiently governed)

> > because it has insufficient resources (glutathione) to

completely

> > rid the body of viral particles; the constantly elevated energy

> > demand of the immune system detracts from other metabolic

> functions

> > (particularly energy-demanding systems such as skeletal muscles

> and

> > the cardiovascular system); limitation of respiratory and

> > cardiovascular systems further locks the patient into a vicious

> > cycle of inefficient energy production and use; increased

reliance

> > on anaerobic metabolism leads to lactic acid production and

> > associated muscle pain.

> > Clearly, the performance of energy-demanding activities such as

> > exercise can only aggravate this situation. Indeed, 82 % of ME

> > patients in a recent study stated that graded exercise therapy

> > worsened their condition, and only 5 % found it useful (compared

> to

> > 70 – 75 % of patients who found either pain management or

`pacing'

> > of daily activities useful)34. Furthermore, the Canadian

Clinical

> > Treatment Protocol warns that " externally paced `Graded Exercise

> > Programs' or programs based on the premise that patients are

> > misperceiving their activity limits or illness must be

avoided " 35.

> > If exercise is so detrimental, why is graded exercise therapy

> often

> > recommended as a treatment for ME? Firstly, many of the studies

> > cited here are recent, and the information and implications have

> > perhaps not yet filtered up to policy makers. Secondly, the

> > reclassification of ME as an ambiguous `chronic fatigue

syndrome'

> > (CFS) by members of the psychiatric profession assumes that the

> > symptoms have no physiological basis and are best treated with

the

> > traditional psychiatric method of facing and overcoming a

problem,

> > rather than direct removal of the problem at source. However,

this

> > approach jumps from hypothesis to treatment without

investigating

> > the mechanisms involved, perhaps explaining why " no psychiatrist

> has

> > ever cured an M.E. patient using psychiatric treatments " 19.

> > Psychiatry, by definition, should not have authority over the

> > treatment of physiological disorders, particularly those that

> occur

> > chiefly in muscle tissues. Graded exercise therapy is founded

on,

> > and perpetuates, the myth that ME patients are simply

malingering,

> > while most are frustrated by their incapacity to satisfactorily

> > conduct critical aspects of daily life34.

> > ME is a heterogeneous disorder that affects different patients

to

> > varying degrees and with subtly different suites of symptoms. At

> > best, graded exercise therapy has relieved symptoms for (but not

> > cured) a tiny minority of patients, whilst the weight of

empirical

> > evidence indicates that exercise has direct and persistently

> > negative impacts on the physiology and quality of life of a

> > significant subgroup of ME patients. Any universally applied

> therapy

> > is unlikely to address the heterogeneity of ME, and graded

> exercise

> > is particularly unsuitable as it may worsen the condition, and

> > should not be generally recommended without a high degree of

> > confidence that it will not be applied to susceptible patients:

it

> > is difficult to conceive of a more inappropriate therapy for ME.

> By

> > increasing the risk of relapse and overall health risks, rather

> than

> > reducing them, graded exercise therapy also risks increasing the

> > burden of illness on society at large. The present review

suggests

> > that an approach based on treatment of the underlying

> physiological

> > dysfunction will be more fruitful.

> >

> > Abbreviations

> > ATP = Adenosine triphosphate, RNase L = 2',5'-oligoadenylate (2-

> 5A)

> > synthetase/Ribonuclease L

> > Literature cited

> > 1 De Becker PJ, Roeykens J, Reynders N, McGregor N & De Meirleir

> K.

> > 2000. Exercise capacity in chronic fatigue syndrome. Archives of

> > International Medicine 160: 3270-3277.

> > 2 Fulcher KY & White PD. 2000. Strength and physiological

response

> > to exercise in patients with chronic fatigue syndrome. Journal

of

> > Neurology, Neurosurgery, and Psychiatry 69: 302-307.

> > 3 Wong R, Lopaschuk G, Zhu G, et al. 1992. Skeletal muscle

> > metabolism in the chronic fatigue syndrome: in vivo assessment

by

> > 31P nuclear magnetic resonance spectroscopy. Chest 102: 1716-

1722.

> > 4 Nus J, De Meirleir K, Wolfs S & Duquet W. 2004. Disability

> > evaluation in chronic fatigue syndrome: associations between

> > exercise capacity and activity limitations/participation

> > restrictions. Clinical Rehabilitation 18: 139-148.

> > 5 Sorensen B. Streib JE, Strand M, et al. 2003. Complement

> > activation in a model of chronic fatique syndrome. Journal of

> > Allergy and Clinical Immunology 112: 397-403.

> > 6 Sargent C, Scroop GC, Nemeth PM, Burnet RB & Buckley JD. 2002.

> > Maximal oxygen uptake and lactate metabolism are normal in

chronic

> > fatigue syndrome. Medicine & Science in Sports and Exercise 34:

51-

> > 56.

> > 7 Chia JKS. 2005. The role of enterovirus in chronic fatigue

> > syndrome. Journal of Clinical Pathology 58: 1126-1132.

> > 8 National Institute for Health and Clinical Excellence (NICE).

> > CFS/ME: full guideline DRAFT (September 2006).

> > 9 Afari N & Buchwald D. 2003. Chronic fatigue syndrome: a

review.

> > American Journal of Psychiatry 160: 221-236.

> > 10 Patarca-Montero R, Antoni M, Fletcher MA & Klimas NG. 2001.

> > Cytokine and other immunologic markers in Chronic Fatigue

Syndrome

> > and their relation to neuropsychological factors. Applied

> > Neuropsychology 8: 51-64.

> > 11 Hooper M. 2006. Myalgic Encephalomyelitis (ME): a review with

> > emphasis on key findings in biomedical research. Journal of

> Clinical

> > Pathology (in press) published online 25 Aug. 2006 doi:

> > 10.1136/jcp.2006.042408.

> > 12 Lane RJM, Soteriou BA, Zhang H, & Archard LC. 2003.

Enterovirus

> > related metabolic myopathy: a postviral fatigue syndrome.

Journal

> of

> > Neurology, Neurosurgery, and Psychiatry 74: 1382-1386.

> > 13 Ayres JG, Flint N, EG, et al. 1998. Post-infection

> fatigue

> > syndrome following Q-fever. Q. J. Med. 91: 105-123.

> > 14 Berelowitz JG, Burgess AP, Thanabalasingham T, et al. 1995.

> Post-

> > hepatitis syndrome revisited. Journal of Viral Hepatitis 2: 133-

> 138.

> > 15 Kerr JR, Barah F, Matley DL. et al. 2001. Circulating tumour

> > necrosis factor-alpha and interferon-gamma are detectable during

> > acute and convalescent paravirus B19 infection and are

associated

> > with prolonged and chronic fatigue. Journal of General Virology.

> 82:

> > 3011-3019.

> > 16 Hotopf M, Noah N, Wesseley S. 1996. Chronic fatigue and

> > psychiatric morbidity following viral meningitis: a controlled

> > study. Journal of Neurology, Neurosurgery, and Psychiatry 60:

495-

> > 503.

> > 17 White PD, JM, Amess J, et al. 1995. The existence of a

> > fatigue syndrome after glandular fever. Psychological Medicine

25:

> > 907-916.

> > 18 Chia JK, Jou NS, Majera L et al. 2001. The presence of

> > enteroviral RNA (EV RNA) in peripheral blood mononuclear cells

> > (PBMC) of patients with the chronic fatigue syndrome (CFS)

> > associated with high levels of neutralizing antibodies to

> > enteroviruses. Clinical Infectious Diseases 33: 1157.

> > 19 Hyde B. 2006. A new and simple definition of myalgic

> > encephalomyelitis and a new simple definition of chronic fatigue

> > syndrome & a brief history of myalgic encephalomyelitis and an

> > irreverent history of chronic fatigue syndrome. Invest in ME, UK.

> > 20 Nijs J, Meeus M, McGregor NR, Meeusen R, De Schutter G, Van

> Hoof

> > E & De Meirleir K. 2005. Chronic fatigue syndrome: exercise

> > performance related to immune dysfunction. Medicine & Science in

> > Sports and Exercise 37(10): 1647-1654.

> > 21 s RS, TK, RH, McGregor NR & Butt HL.

> 2000.

> > Free radicals in chronic fatigue syndrome: cause or effect?

Redox

> > Report 5(2-3): 146-147.

> > 22 y Keenoy B, Moorkens G, Vertommen J, Noe M & De Leeuw

I.

> > 2000. Magnesium status and parameters of the oxidant-antioxidant

> > balance in patients with chronic fatigue: effects of

> supplementation

> > with magnesium. Journal of the American College of Nutrition 19

> (3):

> > 374-382.

> > 23 Kurup RK & Kurup PA. 2003. Hypothalamic digoxin, cerebral

> > chemical dominance and myalgic encephalomyelitis. International

> > Journal of Neuroscience 113: 683-701.

> > 24 Ji LL. 1995. Oxidative stress during exercise: implication of

> > antioxidant nutrients. Free Radical Biology & Medicine 18(6):

1079-

> > 1086.

> > 25 Bounous G & Molson J. 1999. Competition for glutathione

> > precursors between the immune system and the skeletal muscle:

> > pathogenesis of chronic fatigue syndrome. Medical Hypotheses 53

> (4):

> > 347-349.

> > 26 Roederer M, Raju PA, Staal FJT, Herzenberg LA & Herzenberg

LA.

> > 1991. N-acetycysteine inhibits latent HIV expression in

> chronically

> > infected cells. AIDS Research and Human Retroviruses 7: 563-567.

> > 27 Staal FJT, Roederer M, Israelski DM, Bubp J, Mole LA, McShane

> D,

> > Deresinski SC, Ross W, Sussman H, Raju PA, MT, W,

> Ela

> > SW, Herzenberg LA & Herzenberg LA. 1992. Intracellular

glutathione

> > levels in T cell subsets decrease in HIV-infected individuals.

> AIDS

> > Research and Human Retroviruses 8: 305-311.

> > 28 Ciriolo MR, Palamara AT, Incerpi S, Lafavia E, Bue MC, De

Vito

> P,

> > Garaci E & Rotilio G. 1997. Loss of GSH, oxidative stress, and

> > decrease of intracellular pH as sequential steps in viral

> infection.

> > Journal of Biological Chemistry 272(5): 2700-2708.

> > 29 Cai J, Chen Y, Seth S, Furukawa S, Compans RW & DP.

2003.

> > Inhibition of influenza infection by glutathione. Free Radical

> > Biology & Medicine 34(7): 928-936.

> > 30 Van Konynenburg RA. 2004. Is glutathione depletion an

important

> > part of the pathogenesis of chronic fatigue syndrome? Presented

at

> > the AACFS Seventh International Conference, Oct. 8-10/2004,

> Madison,

> > Wisconsin.

> > 31 Salvato P. 1998. CFIDS patients improve with glutathione

> > injections. CFIDS Chronicle January/February 1998.

> > 32 Cheney PR. 1999. Evidence of glutathione deficiency in

chronic

> > fatigue syndrome. American Biologics 11th International

Symposium,

> > Vienna, Austria. Tape No. 07-199: available from Professional

> Audio

> > Recording, P.O. Box 7455, LaVerne, CA 91750.

> > 33 Spence V & J. 2004. Standing up for ME. Biologist 51

> (2):

> > 65-70.

> > 34 25% ME Group. 2004. Severely affected ME (myalgic

> > encephalomyelitis) analysis report on a questionnaire issued

> January

> > 2004. 25% ME Group, Troon, Ayrshire, UK. pp. 8.

> > 35 Jain AK, Carruthers BM & Van de Sande MI. 2004. Fibromyalgia

> > Syndrome: Canadian Clinical Working Case Definition, Diagnostic

> and

> > Treatment Protocols-A Consensus Document. Journal of

> Musculoskeletal

> > Pain 11(4): 3-107.

> >

> >

> >

> >

> >

> >

> > ---------------------------------

> > Any questions? Get answers on any topic at Answers. Try

it

> now.

> >

> >

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...